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SUMMARY 
 
Discovery of novel natural products from soft corals were reported with many 
achievement so far. Soft coral associated bacteria have gained interest for several reasons 
such as for marine environmental protection and bio-mining of natural products from 
microorganism as compared to the animals. This work focused on communities of soft coral 
associated bacteria and on the search for new antimicrobial substances and new natural 
products as potential candidates for new drugs. Thus, soft coral associated bacteria were 
quite abundant and good sources of antimicrobial producers. 
The results from cultivation-based studies and sequence analysis of 16S rRNA genes 
of bacterial communities associated with the soft coral A. digitatum are reported in this 
study. A total of 251 isolates were identified as belonging to 4 phyla Firmicutes, 
Actinobacteria, Gammaproteobacteria, and Alphaproteobacteria. Four of these isolates 
may be new species, 2 isolates of Firmicutes, 1 Gammaproteobacterium and 1 
Alphaproteobacterium. The high diversity of the bacterial communities and their 
antimicrobial activities suggest the contribution of the associated bacteria to the coral 
health. 
The results from antimicrobial tests demonstrated that A. digitatum was the source of 
various bacteria producing antimicrobial substances. Antimicrobial activity of the isolates 
were found only in BM medium (3%), only in GYM medium (2%) or in both of these 
media (44%). Quite significant, all isolates belonging to the two species B. 
amyloliquefaciens and B. methylotrophicus showed antimicrobial activities. Some strains of 
the two species inhibited all four test microorganisms. Chemical analyis revealed that the 
two Bacillus sp. strains produced various known cyclic peptides as well as presumably new 
metabolites. They represented highly potent producers of antimicrobials. All isolates of 
Actinobacteria produced antimicrobial substances, that inhibited particulary Gram-positive 
bacteria.  
In addition to a marine Micrococcus isolate, three isolates of Firmicutes were 
thoroughly studied in regard to analysis of production of new compounds. In addition a 
number of known compounds were identified, including several peptides. The metabolites 
of the four strains were examined and purified by using several HPLC systems. The 
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biological activities of pure compounds were studied using antibacterial, antifungal, 
cytotoxic, and enzyme assays. Eleven compounds were purified and applied to bioassays. 
One of the proposed known cyclic peptides showed antimicrobial activity against both B. 
subtilis and E. coli, whereas the others showed inhibition of methicillin-resistant 
Staphylococcus aureus (MRSA) and phosphodiesterase 4β2. One of compounds, which 
were considered as new compounds, inhibited fungus Trichophyton rubrum and enzyme 
phosphodiesterase 4β2. The structure elucidations of all pure compounds are in progress. 
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ZUSAMMENFASSUNG  
 
Die Entdeckung von biologisch aktiven Substanzen aus Weichkorallen führte bereits 
zu großen Errungenschaften. Bakterien, die mit Weichkorallen assoziiert sind, stehen aus 
verschiedenen Gründen im Mittelpunkt des Interesses. Beispielsweise können sie eine 
Schutzfunktion für die Koralle vor schädlichen Umwelteinflüssen ausüben, zum anderen 
dienen sie der Gewinnung von Wirkstoffen. Die vorliegende Arbeit beschäftigt sich mit den 
Gemeinschaften von Korallen-assoziierten Bakterien sowie mit der Suche nach neuen 
antimikrobiellen Substanzen und nach neuen Wirkstoffen, die als Kandidaten für potentielle 
Medikamente in Frage kommen können. Hilfreich ist hierbei, dass Bakterien, die mit 
Weichkorallen vergesellschaftet sind, sehr häufig auftreten und eine vielversprechende 
Quelle für antimikrobielle Substanzen sind. 
Die Ergebnisse der kultivierungsabhängigen Untersuchungen und die Analyse der 
16S rRNA Gene von Bakterien, die mit der Weichkoralle A. digitatum assoziiert sind, 
werden dargestellt. Insgesamt wurden 251 Isolate identifiziert und den 4 Phyla  Firmicutes, 
Actinobacteria, Gammaproteobacteria und Alphaproteobacteria zugeordnet. Vier dieser 
Isolate sind vermutlich Repräsentanten neuer Arten, von denen zwei zu den Firmicutes, eine 
zu den Gammaproteobacteria und eine zu den  Alphaproteobacteria zählen. Die große 
Diversität der bakteriellen Gemeinschaften und die antimikrobiellen Aktivitäten der 
einzelnen Mitglieder weist auf eine positive Auswirkung der assoziierten Bakterien auf die 
Gesundheit der Koralle hin. 
Die Ergebnisse der antimikrobiellen Testungen zeigten, dass A. digitatum eine gute 
Quelle für verschiedene Bakterien darstellt, die antimikrobielle Substanzen produzieren. 
Nahezu 50% der Isolate war antimikrobiell aktiv. 44% wiesen Aktivitäten sowohl nach 
Anzucht in BM Medium als auch nach Kultivierung in GYM Medium auf. Bei 3% der 
Stämme konnten Aktivitäten nur nach Verwendung des BM Mediums nachgewiesen 
werden, bei 2% nur bei Anzucht in GYM Medium. Auffällig war, dass alle Isolate, die mit 
den Arten Bacillus amyloliquefaciens and Bacillus methylotrophicus verwandt sind, 
antimikrobielle Aktivitäten zeigten. Einige dieser Stämme hemmten sogar das Wachstum 
aller vier Teststämme. Die chemische Analyse zeigte, dass zwei Bacillus sp. Isolate 
verschiedene bekannte zyklische Peptide aber auch vermutlich neue Substanzen 
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produzieren. Alle Isolate der Actinobacteria produzierten Substanzen, die vor allen Gram-
positive Bakterien hemmten. Diese Stämme haben eine hohes Potential zur Produktion 
neuer antimikrobieller Wirkstoffe. 
Sowohl ein Micrococcus sp. Isolat als auch drei Firmicutes sp. wurden ausführlich 
in Bezug auf die Bildung neuer Substanzen hin untersucht. Eine Anzahl bekannter 
Strukturen wurde identifiziert, einschließlich verschiedener Peptide. Die Metabolite der vier 
Stämme wurden untersucht und mittels unterschiedlicher HPLC- Systeme aufgereinigt. Die 
biologischen Aktivitäten von insgesamt 11 Reinsubstanzen gegen Bakterien, Pilze, 
Tumorzelllinien und Enzyme wurden ermittelt. Eines der bekannten zyklischen Peptide 
hemmte das Wachstum von B. subtilis and E. coli. Andere Peptide hemmten den Methicillin 
resistenten Staphylococcus aureus (MRSA) Stamm und das Enzym Phosphodiesterase 4β2. 
Eine Substanz, die vermutlich neu ist, wirkte gegen den Pilz Trichophyton rubrum and 
Phosphodiesterase 4β2. Die Strukturaufklärung aller Reinsubstanzen läuft derzeit noch. 
 
Introduction 
 
5 
 
INTRODUCTION 
 
1. Soft coral Alcyonium digitatum (Linnaeus, 1758) 
Like sponges, soft corals are sessile filter feeders. The coral polyps are colonial form 
with 8 tentacles which capture prey form water column. Like hard corals, soft corals exude 
mucus by their polyps. Coral mucus plays a very important role as energy carrier and 
particle trap in the reef ecosystem (Wild et al. 2004; Bythell and Wild, 2011). The polyp 
conveys oxygen and brings a supply of food as mucus via coral mouth thorough hollow 
polyp body that has cylindrical shape. Unlike hard corals, soft corals have numerous tiny, 
needle-like spicules in their tissues. The spicules give these corals some physical support 
and give spiky and grainy texture of the polyps and colonies that deters predators (van 
Alstyne et al. 1992). 
The soft coral Alcyonium digitatum is a species of the Alcyoniidae family, order 
Alcyonacea, class Anthozoa, phylum Cnidaria. It is a common boreal species. Its habitats 
are found around the Atlantic coast of North West Europe from Portugal to Norway, with 
further reports from Britain, Ireland and found in North America. In the Irish Sea, this 
species is abundant and is commonly dominant in strong current movement where the 
otherwise algae are limited due to lack of light (Robin, 1968; Hartnoll, 1975). In the 
absence of current flow, the pattern of expansion and contraction of polyps and tentacle of 
A. digitatum was not different during light (day time) and dark (night time) periods. 
However, under high flow conditions, coral polyps and tentacles expanded greatly (Bell et 
al. 2006). 
There are two distinct colours with orange morphs and white morphs. The sex ratio 
is nearly equal to each colour form. The majority of colonies are either male or female. 
Hermaphrodites were not found amongst several hundred colonies (Hickson, 1895). 
However, later hermaphrodites were observed in this soft coral at the same study area 
(Hartnoll, 1975; Matthews, 1917). The largest specimen has a height of 10 cm, a width of 
20 cm and a weight of 1 kg between 5 and 10 years old. The life span certainly exceeds 20 
years (Hartnoll, 1975). 
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This soft coral expands and feeds regularly from February to July. The colonies of 
A. digitatum remain contracted for a long period from late July to December, during which 
time they do not feed and assume a shrunken appearance with a reddish or brownish colour 
(Figure 1.1). Due to long quiescent period inactivity, the surface of colonies of Alcyonium is 
attractive for foreign settlement. It has been noted, “the ectoderm is almost invariably 
covered by a coat of transparent mucus, in which grains of sand, minute algae and other 
foreign bodies occur” (Hickson, 1895). Diatoms, prostrate thalloid, filamentous algae, 
hydroid, and amphipod are contributed into film of epibiota on the surface of coral colonies 
(Hartnoll, 1975). 
 
Figure 1.1 The annual cycle of A. digitatum. The upper part shows the variation in the proportion of 
colonies with a prominent film of epibiota on the surface. The lower part shows the maturation of 
gonads (Hartnoll, 1975). 
 
Small gonads already exist in December and January at that time when the ripe 
gametes matured over the previous year are being spawned. The prolonged inactivity 
coincides with the final months of gonad maturation and the film of epibiota slough off 
immediately precedes the spawning of the gametes. Gametes are expelled from the mouths 
of the partly expended polyps into the ambient water and fertilization occurs externally 
(Hartnoll, 1975). The spawning of a colony takes several consecutive days. The zygotes 
Introduction 
 
7 
 
develop to planulae (free-swimming larva of a cnidarian) after 5 to 7 days and most 
planulae settle and metamorphose to polyps within one or two following days (Matthews, 
1917). 
The soft coral A. digitatum from the Atlantic coast of Scotland were examined for 
chemical defences. Methanol extracts of both corals contained substances acting as feeding 
deterrents for the test fish Dover sole Solea solea (Mackie, 1987). 
 
2. Bacteria and coral hosts 
2.1 Where we found the bacteria in coral hosts?  
For now, there is no article that deals with the bacteria localized in soft coral. 
Microorganisms found in hard coral host are shown in Figure 1.2. In this model, hard coral 
Oculina patagonica was examined, microorganism were found from mostly whole of coral 
colony (Rosenberg et al. 2007).  
 
Figure 1.2 Microorganisms in coral host (Rosenberg et al. 2007). 
 
 
Studies of the diversity of microorganisms associated with soft coral A. antarcticum 
by transmission electron microscopy (TEM) reported that bacteria were detected in the 
surrounding of the epidermis but not in the subcuticular layers and the mesoglea. However, 
except epidermis and tentacle regions, bacteria were found within most areas of the coral 
tissue. Particular high densities of bacteria were detected in the gastro vascular and 
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mesentery regions by fluorescence in situ hybridization (FISH) (Webster and Bourne, 
2007). 
In soft corals, bacteria can be found in mucus layer, coral tissues and also in spiny 
skeletal elements called sclerites but not in the skeleton of hard coral. Because of the most 
untapped sources, soft coral associated bacteria are likely to lack of information in 
comparison with sponge-associated microorganisms. The contribution of microorganism to 
contribute to sponge biomass was found in some sponges to amount to 40% of the sponge 
biomass (Imhoff and Stöhr, 2003). However, concerning occupation, location, and quantity 
of bacteria in soft corals no specific information is available. 
 
2.2 Coral associated bacteria 
Corals are of particular interest for scientific research for several reasons. On the one 
hand, effects of climate change are proposed to have a major impact on coastal zone 
ecosystems in general and on coral reefs in particular. It has been predicted that over 50% 
of the coral reefs in the world may be destroyed by the year 2030 by global climate change 
mediated temperature increase (Lough and Barnes, 2000). On the other hand, 
microorganisms associated with marine invertebrates such as sponges, corals and algae are 
potent producers of biological active substances with prominent activities and a rich source 
of novel compounds (Imhoff et al. 2011). 
Because of human diseases such as cancer, microbial infections and inflammatory 
processes as well as quickly increasing antibiotic resistance, the search for antimicrobials 
becomes more and more urgent. Research on bacterial communities and their antimicrobial 
compounds from marine microorganisms has focused on associations with sponges 
(Muscholl-Silberhorn et al. 2008; Thiel and Imhoff, 2003; Thiel et al. 2007), algae (Wiese 
et al. 2009), ascidians (Tait et al. 2007), holothurian (Ward-Rainey et al. 1996), protozoa 
(Heindl et al. 2010) and mollusks (Romanenko et al. 2008). Bacteria, fungi, and algae were 
isolated from soft corals as well and some displayed antifouling activity (Slattery et al. 
1995).  
Research on bacteria associated with corals has been focussed on hard corals. 
Studies on the genetic diversity of bacteria associated with corals have revealed extreme 
species richness and abundances. A vast number of distinct bacterial groups were found 
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from both coral tissues and coral mucus. Proteobacteria (Gamma-, Alpha-, and 
Betaproteobacteria) were revealed as most abundant coral associated bacteria (Rohwer et 
al. 2001; Rohwer et al. 2002; Frias-Lopez et al. 2002; Lampert et al. 2008; Bourne and 
Munn, 2005). Analyses of the diversity of marine microorganisms via molecular techniques 
have made many advances within the last 15 years. However, many bacteria that can be 
detected by DNA sequences in the environmental sample cannot be grown on agar plates 
and in culture media under standard conditions (Pedros-Alio, 2006). Nevertheless, 
traditional methods and cultivation in pure culture are still needed in order to determine the 
physiological properties and e.g. the ability to produce antimicrobial compounds and 
determine their biological activities. 
Using culture-base methods, 16S rRNA gene sequence analysis, biochemical testing 
and antimicrobial susceptibilities have been employed to analyse the diversity of marine 
microorganisms in mucus of the hard coral Fungia scutaria in the Red Sea (Lampert et al. 
2006), and a cold water coral Lophelia pertusa  in the deep sea (Galkiewicz et al. 2011). It 
was shown that the main bacterial groups associated with the mucus of F. scutaria were 
identified as Gammaproteobacteria, Alphaproteobacteria and Actinobacteria and that more 
than 30.0% of the 22 different isolates belonged to novel species and a new genus (Lampert 
et al. 2006). Gammaproteobacteria were also the most abundant bacteria associated with 
the cold water coral L. pertusa, but Betaproteobacteria and Actinobacteria were found in 
addition (Galkiewicz et al. 2011). A study on cultured bacteria associated with the 
gorgonian corals Paragorgea arborea, Plumarella superba, and Cryogorgia koolsae from 
the Aleutian Islands reported that Gammaproteobacteria, Alphaproteobacteria, 
Bacteroidetes, and Actinobacteria were most abundant (Gray et al. 2011). By a culture 
dependent approach, a total of 36 bacterial strains were recovered and identified from the 
black coral. They belonged to three bacterial phyla i. e. Firmicutes, Actinobacteria and 
Alphaproteobacteria. In addition 24 fungal isolates affiliated to four fungal orders 
Eurotiales, Hypocreales, Pleosporales and Botryosphaeriales. A high proportion (51.6%) 
of microbial isolates displayed distinct antibacterial and antifungal activities (Zhang et al. 
2012). Isolates (a total of 76) from four species of South China Sea gorgonians were 
affiliated to 21 species in 7 genera and most abundant were representatives of the genus 
Bacillus which exhibited a high antimicrobial potential (Peng et al. 2013). 
Pseudoalteromonas spp. and Vibrio spp. were most dominant among isolates from the coral 
Acropora millepora in the Great Barrier Reef and displayed good antimicrobial activity 
against a range of bacteria (Kvennefors et al. 2012). Bacteria associated with the hard coral 
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Acropora digitifera from Hare Island, the Gulf of Mannar were assigned to Firmicutes, 
Gammaproteobacteria and Actinobacteria. Both isolates from coral mucus and from coral 
tissue showed antimicrobial activity. The presence of Actinobacteria was established in 
both the coral mucus and the coral tissue. They produced substances with high activity 
against pathogens Staphylococcus aureus (ATCC11632), Pseudomonas aeruginosa 
(ATCC10145), Aeromonas hydrophila (ATCC7966), Vibrio parahaemolyticus 
(ATCC27519), and Vibrio vulnificus (ATCC29307) (Nithyanand and Pandian, 2009). 
Roseobacter sp. isolated from mucus of the Mediterranean coral Oculina patagonica 
displayed a broad spectrum of antimicrobial activities against the coral pathogens Vibrio 
coralliilyticus and Thallassomonas loyana. This finding suggested the possibility of 
probiotic effects on microbial communities to the coral holobiont (Nissimov et al. 2009).  
Quite a few studies have so far been reported on bacteria associated with soft corals 
and their antibiotic activities. The study of bacterial communities of soft corals 
Dendronephthya sp. in Port Shelter, Hong Kong reported a distinctive epibiotic community, 
of which 55.0% belonged to the Gammaproteobacteria, 27.0% to the Alphaproteobacteria, 
and 18.0% to the Bacteroidetes, respectively (Harder et al. 2003). The bacteria associated 
with Dendronephthya sp. were thought to be contributing to antifouling mechanisms, 
because they could inhibit larval settlement of the tubeworms Hydroides elegans 
(Dobretsov and Qian, 2004). The diversity of bacteria associated with the soft coral 
Alcyonium antarcticum from Ross Sea, Antarctica was investigated across three different 
contaminated sites by culture-based and molecular techniques (denaturing gradient gel 
electrophoresis-DGGE, 16S rRNA gene clone library, and FISH). Phylogenetic analysis of 
these bacteria showed a close affiliation with psychrophiles from the Antarctic region and 
high abundance of Gammaproteobacteria clades. This study supported the view that 
specific coral-microbial interactions exist (Webster and Bourne, 2007).  
In a comparative study between stony corals and soft corals, bacteria associated with 
six stony corals (Platygyra sp., Porites sp., Fungia granulosa, Favia sp., Stylophora sp. and 
Pocillopora sp.) had a higher percentage of antibiotic activity as compared to bacteria 
associated with two soft corals Rhytisma fulvum and Xenia sp. (Shnit-Orland and 
Kushmaro, 2009). 
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3. Biotechnological potential of soft corals and coral associated bacteria 
Marine invertebrates are considered to be a promising source of bioactive 
compounds to investigate drugs from the sea. Beside foremost good candidate sponges, 
cnidarians now attract many scientists to exploit marine natural products (MNPs). The soft 
corals (order Alcyonacea) have contributed with 98.1% of new natural products from sub-
class Octocorallia that belongs to the class Anthozoa. The class Anthozoa consisted 99.0% 
of MNP reported from Cnidaria (Leal et al. 2012). They were most interesting compounds 
such as antitumor, anti-human immunodeficiency virus, anti-inflammatory, antifouling, 
antiulcer, and antimicrobial compounds. Antitumor drugs are the main area of interest in the 
screening of MNPs from cnidarians (41.0%, Figure 1.3).  
  
 
 
Figure 1.3 Distribution in drug classes of marine bioactive compounds with high biotechnological 
potential studied from cnidarian species (Rocha et al. 2011). 
 
A total of 5,286 natural products were reported in the last decade (2000 to 2009), 
most of them were terpenoids (40.5%). Cnidaria were the sources of terpenoids with 54.5% 
of the total of 2,256 natural products (NPs) (Leal et al. 2012). Rocha et al. (2011) reported 
that terpenoids (terpenoid, diterpenoid, sesquiterpenoid, sesterterpenoid, cembranoid) are 
the main chemistry group within the MNPs analysis (61.0%). 
Introduction 
 
12 
 
It is clear that Cnidaria (especially in order Alcyonacea and order Gorganacea) are a 
rich source of bioactive compounds. Today over 3000 MNPs have been described from this 
phylum, most in the last decade (Rocha et al. 2011). Although significant chemical diversity 
and promising candidates for drug development were revealed from Cnidaria, to the best of 
our knowledge, no metabolite from them has yet reached the further investigation such as 
pharmaceutical clinical pipeline or entered clinical trials. 
Over 200 species of hard corals (2/3) and soft corals (1/3) were harvested every year 
from coral reefs to supply the marine aquarium trades. However, NP discovery has been 
focused on soft corals much more than on hard corals because of biased bioprospecting 
efforts. Screening efforts have been made with around 30 stony coral species in comparison 
with approximately 300 soft coral species (Blunt and Munro, 2012). Coral mariculture (in 
situ) and captive breeding (ex situ) are offered to provide material for drug discovery. In 
view of the fat, that coral aquaculture is still in its infancy and has a number of unresolved 
problems that need to be considered, a number of questions need to be answered, e.g. who is 
producer of the compounds, the host or the associated microorganisms and what drives 
metabolite production? How can metabolite production be optimized? (Leal et al. 2013). 
Although marine invertebrates show a huge diversity of metabolites, increasing 
evidence suggested that their symbiotic microorganisms are the true sources of these 
bioactive compounds in many instances, most obviously in the case of sponges (Piel, 2004). 
Corals were no exception. The pseudopterosin, a potent anti-inflammatory inhibitor of 
diterpene cyclase, was obtained from the marine octocoral Pseudopterogorgia elisabethae 
(Roussis et al. 1990; Correa et al. 2011) and was used in commercially available skin care 
products. However, the site of biosynthesis of pseudopterosin was found in a macroalgal 
preparation by using differential centrifugation and it was concluded that the coral symbiont 
dinoflagellate Symbiodinium sp was the original pseudopterosin producer (Mydlarz et al. 
2003). 
Additionally, the significant increase of the number of NPs isolated from marine 
microorganisms demonstrated their attraction for scientists in efforts to exploit new natural 
compounds.  
A summary of the number of NPs isolated from sponges, cnidarians and marine 
microorganisms from 2008 to 2012 is shown in Table 1.1. Data sources are found in the 
reviews of Blunt et al. (2010-2014).   
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Table 1.1 Number of NPs reported from sponges, cnidarians and marine microorganisms. 
Sources 
Years 
2008 2009 2010 2011 2012 
Sponges 278 287 283 296 355 
Cnidarians 264 201 188 290 213 
Marine microorganisms 208 273 312 405 ˃ 450 
 
In contrast to soft corals harvested for NPs research (normally in large amounts of 
kg), only tiny amount of the original samples are needed to isolate microorganism. 
Cultivation, change in cultivation conditions and other factors to optimize natural product 
production is easily implemented.  
Biological activity of coral-associated bacteria is not only restricted to activity 
against bacteria, fungi but has also been found against tumour cell lines, for example the 
cyclic depsipeptide thiocoraline which showed antitumor activities (breast, colon, renal, and 
melanoma) and was obtained from a Micromonospora isolate derived from an unidentified 
soft coral collected in the Indian Ocean near the coast of Mozambique (Romero et al. 1997).  
Therefore, studies of microorganisms associated with soft corals can lead to answer the 
question about the host and pathogen and can open interesting research in term of exploiting 
new drug from nature. 
The present study for the first time analyses the diversity of bacteria associated with 
the soft coral Alcyonium digitatum and their antimicrobial activities using culture-based 
approaches and 16S rRNA gene analysis to identify the isolates. 
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4. Thesis outline 
 The diversity of hard coral associated bacteria has been reported so far, however, there 
were only few reports on soft coral associated bacteria. Searching of new metabolites from 
marine bacteria associated with corals has been increased recently. It is clear that research 
on soft coral associated bacteria now is at its beginning. The aim of this study is the 
investigation of the diversity and the biotechnological potential of bacteria associated with 
the soft coral Alcyonium digitatum. In particular, three objectives were addressed: 
Diversity of bacteria associated with the soft coral by cultivation-dependent approach. 
Soft corals were sampled in the Baltic Sea for the investigation of bacterial communities 
and the antimicrobial activities of the isolates. Soft coral associated bacteria were isolated in 
four different media and at two different temperatures. The diversity of isolates was 
conducted by using of cultivation based methods and 16S rRNA gene sequence analysis. 
The sequences were compared with BLAST/NCBI. By the other hand, cultivation 
dependent work also pays the way for searching of bioactive compound producer bacteria. 
 
Antimicrobial activities of the isolates. All bacterial isolates obtained in the cultivation 
studie were analysed in regard to the production of new metabolites. The antimicrobial 
activities of the isolates were screened in two different media. Broth cultures were extracted 
by organic solvent and tested for antimicrobial activity against a standard set of Gram-
negative (Escherichia coli) and Gram-positive bacteria (Staphylococcus epidermidis and 
Bacillus subtilis) and a human pathogenic yeast (Candida albicans). The crude extracts also 
were applied for chemical screening with high-performance liquid chromatography diode 
array detection mass spectrometry (HPLC-DAD-MS), and dictionary of natural products 
(DNPs). 
 
Discovery of natural products from coral associated bacteria. Based on data of metabolites 
and antimicrobial activites, the following strains were chosen for scale up big volume 
cultivation: Inhibition of all four test organisms or specific inhibition (one test organism), 
possible new metabolite producers, easily to growth in screening media. The natural 
substance were purified with several HPLC. The pure compounds were conducted both 
chemical and biological analyses in order to identify the biological activity and identify the 
antimicrobial substances. 
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MATERIAL AND METHODS 
 
1. Sampling and cultivation processes 
Nine living soft coral colonies Alcyonium digitatum with white or orange colour 
were randomly collected at three difference sampling sites (Table 3.1). All the sampling 
sites were located in the Baltic Sea.  
Three soft coral colonies were collected at each station. To remove loosely attached 
microbes from their surfaces, the soft corals were washed three times with 0.2-μm-filtered 
sterile seawater for 5 minutes. Each colony was cut into 4 branches with a sterile scalpel, 
and 3 out 4 branches were stored in 50 ml tubes and kept in -10
o
C for molecular analysis. 
The last branch was kept in 16 ml of filtered-sterile Baltic Sea water in a 50 ml tube and 
stored at 4
o
C until cultivation.  
The soft coral samples from 16 ml of filtered-sterile Baltic seawater were 
homogenised with Ultraturrax (IKA T25 basic; 30 s, 17.500 speeds; steel tip sterilized with 
70% ethanol and washed with filtered seawater immediately before use). Ten-fold serial 
dilutions of the homogenised samples were prepared to a dilution of 10
−5
 and 100 μL of 
each dilution were spread into triplicate on 4 differed media.  
 Tropic Marine Medium (TM) 
 
5.0 g Peptone from soya bean Merck 
1.0 g         Yeast extract  Bacto 
15.0 g Agar  Difco 
30.0 g Tropic marine salt Wartenberg/Angersbach 
1000 ml Distil water   
 
 Baltic Seawater Medium (BS) 
 
 15.0 g Tropic Marine Salt Wartenberg/Angersbach) 
 15.0 g Agar  Difco 
 1000 ml Baltic Sea water (filtrated, 15°/oo) Whatman (0.2 µm) 
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 R2A Medium (R2A) 
 
0.5 g Yeast extract  Bacto 
0.5 g Proteose peptone Bacto  
0.5 g Casamino acids  Bacto 
0.5 g Glucose x H2O Merck 
0.5 g  Soluble starch  Merck 
0.3 g Sodium pyruvate Roth  
0.3 g K2HPO4    Merck 
0.05 g MgSO4 x 7H2O Merck 
15.0 g Agar  Difco 
30.0  g Tropic marine salt Wartenberg/Angersbach 
1000 ml Distil water  
 
 Seawater Medium (SW)  
 
5.0 g Proteose peptone Bacto 
2.5 g Yeast extract  Bacto 
1.0 g Glucose x H2O Merck 
0.2 g K2HPO4   Merck 
0.05 g MgSO4 x 7H2O Merck 
15.0 g Agar  Difco 
15.0  g Tropic Marine Salt Wartenberg/Angersbach 
1000 ml Baltic Sea water (filtrated, 15°/oo) Whatman (0.2 µm) 
Plates were incubated at 28°C. For isolation of slow growing bacteria plates were 
incubated at 10°C for several months. Representatives of each colony morphotype were 
serially streak-plated onto fresh media to obtain pure isolates. The pure isolates were 
conserved in 1000 μL Cryobank System tubes (Mast Diagnostica GmbH Reinfeld, 
Germany) following manufacturer and stored at -80
o
C. 
 
2. DNA extraction and phylogenetic classification 
Freshly and pure colony from a culture of each morphotype was suspended in 100 µl 
of DNA-free water for molecular biology (Sigma-Aldrich, USA). The bacterial suspension 
was centrifuged at 10,000 rpm/min for 15 min at 4
o
C, after taking off the supernatant, the 
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cells were re-suspended into 200 µl DNA-free water, added silica beads 0.1 mm diameter 
(BioSpec Products-Roth) and shaken with bead mill (type MM200, Retsch, Germany) for 6 
minutes at 30 Hz/s frequency. The lysed bacterial suspensions were centrifuged at 10,000 
rpm for 5 min. The suspension contained of extracted DNA was directly used for 
polymerase chain reaction (PCR) or stored at -20
o
C for subsequent analyses.  
Amplification of the 16S rRNA fragment was performed using the universal 
primers, forward primer 27f (5′-GAGTTTGATCCTGGCTCAG-3′) and reverse primer  
1492r (5′-GGTTACCTTGTTACGACTT-3′) or 1525r (5′-CGGGCGGTGTGTACAAGG-
3′) (Lane, 1991) in puReTaq™Ready-To-Go™ PCR Beads (Heathcare) with final volume 
of 25 µl including of 5 µl of DNA template, 1 µl of each primer at final concentration of 10 
µM and H2O (BioChemika, Sigma-Aldrich). PCR was performed with following conditions 
initial denaturation (2 min at 94°C) followed by 30 cycles of primer annealing (40s at 
50°C), primer extension (90s at 72°C), and denaturation (1 min at 42°C), a final primer 
annealing (1 min at 42°C), and a final extension (5 min at 72°C).  
To check the available of 16S rRNA gene in PCR products before applying to 
sequence, the PCR products were run in the gel electrophoresis. The gel was made with 2% 
agarose (Biozym, Germany) in 1 x TBE (1 mol/L Tris, 0.83 mol/L Boric acid, 10 mmol/L 
Na-EDTA) and dyed with SYBR Gold stain (Invitrogen). PCR products were mixed with 
gel loading blue (BioLabs, Germany) and loaded into the gel. Then, gel was run for 25 
minutes at 150 volt (Power Pack P25, Biometra, Germany) and visualized under UV light 
(UV systeme, Fisherbrand). The presence of 16S rRNA in PCR products were compared to 
the DNA marker (Marker X, Roche, Germany) on the same gel.  
Sequencing was performed with two forwards primers 342f (5′-
TACGGGAGGCAGCAG-3′), 790f (5‟-GATACCCTGGTAGTCC-3‟), and reverse primer 
543r (5′-ATTACCGCGGCTGCTGG-3′). All sequences were done at the Institute for 
Clinical Molecular Biology (University Hospitals Kiel, Germany). Sequence data were 
edited with SeqMan™II (DNAStar) and next relatives were determined by comparison to 
16S rRNA genes from the National Centre for Biotechnology Information (NCBI) GenBank 
using database basis local alignment search tool (BLAST) searches (Altschul et al. 1990).  
Type strain relatives of all isolates were determined by comparison of 16S rRNA 
genes using and the Ribosomal Database Project II (RDP-II) Sequence Match Program 
(Cole et al. 2014) and the tool “Align two or more sequences”/Nucleotide blast/NCBI 
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(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Isolates with the same type strain were grouped 
into arbitrary taxonomic units (ATUs). 
 
3. Extraction procedure for all isolates 
The screening bacteria were re-cultivated in the fresh tropic marine (TM) agar 
medium for 3-5 days before inoculating into 300 ml Erlemeyer flasks containing of 100 ml 
medium GYM (glucose 4 g/l, yeast extract 4 g/l, malt extract 4 g/l, tropical sea salt 15 g/l ) 
and Bannett medium-BM (yeast extract 1 g/l, beef extract 1 g/l, tryptone Bacto 2 g/l, 
glucose 10 g/l, tropic marine salt  20 g/l) for 3 day cultivations with shaking at 120 rpm and 
28
o
C.  
The metabolites from both supernatant and bacterial cell were homogenised by using 
of UltraTurrax T25 basic (IKA-Werke GmbH & Co., Staufen, Germany) for breaking the 
cell at 17.500 U/min for 30s. The homogenised broth was extracted with ethyl acetate with 
ratio 1/1 (volume/volume). Then crude extracts were dried by vacuum rotation (Buchi, 
Switzerland). Dried extract were re-suspended in 1 ml of methanol (Merck). The extracts 
were applied to High-performance liquid chromatography diode array detection mass 
spectrometry (HPLC-DAD-MS) for chemical screening as well as used for antimicrobial 
tests with four organisms for antimicrobial screening. 
 
4. Chemical and antimicrobial screening  
Deionized water was purified by Milli-Q system (Millipore, Bedford USA). MiQ 
water, methanol (grade for HPLC-Merk) and acetonitrile (Sigma Aldrich) were used as 
solvents for HPLC. Solvent A: MiQ + 0.1% formic acid (FA), solvent B: Acetonitrile 
(ACN) + 0.1% FA. 
All samples were dissolved in methanol and filtered through 0.2 µm PTFE syringe 
filter (Grahpic Controls-Germany) before applying in HPLC. 
4.1 Chemical screening   
The crude extracts were subjected to HPLC-DAD-MS using reversed phase C18 
column (C18 column, size 100 x 3.00 mm-Phenomenex Onyx Monolithic) with solvent A 
and solvent B, application with gradient: 0 min 5% B, 4 min 60% B, 6 min 100% B flow 2 
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ml/min on the Hitachi Elite LaChrom system. By using of ion trap detector (Esquire 400, 
Bruker Daltonics) along with LaChrom system to detect the mass. The samples were 
measured at positive mode. 
 Hitachi Elite LaChrom system (standard HPLC) contained organizer, diode array 
detector L 2450 (DAD), pump L 2130, column oven L 2300, and autosampler L 2200. 
The mass spectra and UV chromatography of the metabolites were analysed by 
using of Bruker Daltonics-CompassAnalysis 4.0 and Compasshystar Post Processing 
software respectively. Molecular weight, UV maxima and biological sources were used for 
identification of the compounds by using of dictionary of natural products DNPs (database 
DNPs, 2012). 
Compounds were marked as unknown or possibly new compound when there was 
no hit from data of literature by searching of molecular weight, UV maxima and biological 
sources. The structures of possible known compounds were modified from the structure 
from database by searching of PubChem Compound (http://www.ncbi.nlm.nih.gov).  
 
4.2 Antimicrobial activities screening 
The determination of the antimicrobial activity was carried out on extracts from all 
isolates. The following test organisms were used: B. subtilis DSM 347 and S. epidermidis 
DSM 20044 as representatives of Gram-positive bacteria, E. coli DSM 498 as a Gram-
negative strain, and the yeast C. albicans DSM 1386, all obtained from the German Culture 
Collection (DSMZ, Braunschweig, Germany).  
TSB medium (1.2% tryptic soy broth, 0.5% NaCl) and M186/3 medium (0.1% yeast 
extract, 0.1% malt extract, 0.17% peptone from soybeans, 0.33% glucose) were used for 
bacteria and yeast cultivation, respectively. The indicator organisms were prepared 
overnight cultivation, diluted to an optical density (600 nm) of 0.01-0.05. 200µl of the cell 
suspension indicator organisms were added to each 96-well microtiter plate containing of 
10µl of the crude extracts. 10μl of a resazurin solution (0.2 mg ml-1 phosphate-buffered 
saline) was added to each well after 5 h incubation of microtiter plates at 37
o
C. Then the 
microtiter plates were continuous incubated at 37°C for 5-30 min. 
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To evaluate cell viability, the reduction of resazurin to resorufin was assessed by 
measuring the absorbance 600 nm (reference 690 nm).  The resulting values were compared 
with a positive (10 μM chloramphenicol for bacteria; 10 μM nystatin for the yeast) and a 
negative control (no compound) on the same plate. 
 
5. Cultivation and extraction procedures for four selected strains 
Selected strains were re-cultivated in the media used for their isolation (TM for C-2-
29, C-1-10, R2A for H-6, and SW for A-2-28) for 2 days at 28
o
C. Then the isolates were 
inoculated in 2 litre Erlemeyer flasks containing of 1 litre of GYM (for C-2-29, A-2-28, and 
C-1-10) or BM (for H-6) media. Cultures were shaken at 120 rpm, 28
o
C for 4 days. The 
broth cultures were homogenised by breaking of the bacterial cell with UltraTurrax T25 and 
extracted two times with ethyl acetate 1:1 (v/v). After evaporation 0.05 mg of crude 
extract/ml methanol was applied to standard HPLC for analysis of interested compounds 
before applying to preparation. 
 
6. Compound purification of four selected strains 
As mentioned above, MiQ water, methanol and acetonitrile as well as solvents A 
and B were used as solvents for preparative HPLC. All samples were dissolved in methanol 
and filtered before applying in preparative HPLC. 
6.1 Preparative HPLC with the VWR International LaPrep system 
VWR International LaPrep system consisted of column C18 110A AXIA, 100 x 
50.00 mm (Phenomenex Gemini), pump P110, detector P311, autosampler smartline 3900 
(Knauer), dynamic mixing chamber (Knauer), fraction collector: LABOCOL Vario 2000. 
Specific gradient of solvent A and solvent B were applied in this HPLC system for 
selected samples. VWR International LaPrep system separates the compounds or fractions 
by monitoring absorption at wavelength. Therefore, many of compounds were collected 
with this system. All products were contained in fractions and collected automatically into 
test tubes 180x18 mm (Reagenzgläser, Assistant, Germany). The solvents were removed by 
rotation vacuum. Then, fractions were re-suspended in methanol and transferred in storage 
vials (11.6x32 mm, Macherey-Nagel, Germany). Methanol was evaporated by gas N2 at 
Material and Methods 
 
21 
 
40
o
C and stored at 4
o
C. The purification of separated compounds was checked by standard 
HPLC.  
6.2 Preparative HPLC with the Merck Hitachi Elite LaChrom system 1 
Merck Hitachi Elite LaChrom system 1 included reversed phase C18 110A AXIA 
column, size 100 x 21.20 mm (Phenomenex Gemini), organizer, autosampler L 2200, and 
diode array detector DAD L 2450. 
Selected extracts and selected fractions were carried out separation with semi 
preparative HPLC in order to get pure compounds. With this system all products were 
manually collected with visible UV signals. All further steps to get pure compound were 
implemented as mentioned above.  
6.3 Preparative HPLC with the Merck Hitachi Elite LaChrom system 2 
Merck Hitachi Elite LaChrom system 2 consisted of 00G-4336-P0-AX Synergi 4u 
Polar-RP 80A column, size 250 x 21.20 mm 4 micron (Phenomenex), organizer, 
autosampler L 2200, and diode array detector DAD L 2450. 
The different between LaChrom systems 1 and 2 was column, alternative the column 
was thought to benefit to purification of different compounds, so that the LaChrom system 2 
was used for separation of selected fraction and for purify impure compounds. 
 
7. Bioassays of purified compounds  
The B. subtilis (DSM 347), S. epidermidis (DSM 20044), Staphylococcus aureus 
MRSA (DSM 18827), and Propionibacterium acnes (DSM 1897) were representatives of 
Gram-positive bacteria in addition E. coli (DSM 498) and Klebsiella pneumoniae (DSM 
30104) were used for Gram-negative test. C. albicans (DSM 1386), Septoria tritici and 
Trichophyton rubrum were employed for antifungal tests. G. Rimbach (University of Kiel, 
Germany) kindly provided the mouse fibroblast cell line (NIH-3T3). The human 
hepatocellular carcinoma cell line (HepG2) was obtained from the German Collection of 
Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). Those cell lines were 
implemented for cytotoxic assays. Four enzymes acetylcholinesterase (AchE), glycogen 
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synthase kinase, phosphodiesterase 4 (PDE-4β2) and protein-tyrosine-phosphatase were 
used for enzyme inhibition assays.  
Antimicrobial activity test against B. subtilis, E. coli and P. acnes were performed as 
described by Schneemann et al. (2010). Antimicrobial testing in the same manner as S. 
epidermidis were applied for S. aureus MRSA and K. pneumoniae according to Silber et al 
(2013). A phytopathogenic S. tritici and a dermatophyte T. rubrum were tested according to 
Jansen et al. (2013). The cytotoxic activity against NIH-3T3, HepG2, and inhibitory against 
phosphodiesterase (PDE-4β2) were determined according to Schulz et al (2011). Inhibitory 
activity against acetylcholinesterase (AchE) and the human pathogenic yeast C. albicans 
were performed according to Ohlendorf et al (2012). The enzyme inhibition test for 
glycogen synthase kinase-3β was performed according to Baki et al. (2007) and the test for 
protein tyrosine phosphatase was implemented following to Helaly et al. (2009). 
The final concentration of the pure compounds used in the assays was 100 µM for 
antibacterial and antifungal activity, 50 µM for cytotoxic activity, and 10 µM for enzymatic 
inhibition. 
 
8. NMR analyses 
NMR spectra were analysed on Bruker DRX 500 (500 and 125 MHz) for 1H and 13C 
NMR, respectively, using the residual solvent signals δH 3.31 ppm and δC 49.0 for MeOD4 
as internal references. Measurements of high-resolution mass spectra were performed on a 
benchtop time -of flight spectrometer (mirOTOF-II, Bruker) with positive ESI. NMR 
measurement was performed at the Otto-Diels Institute of Organic Chemistry (Christian-
Albrechts University of Kiel). 
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RESULTS 
 
1. Phylogenetic analysis and identification of the isolates 
The bacterial community of soft coral Alcyonium digitatum as represented by 251 
pure culture isolates is composed of Firmicutes (4 genera, 23 species), Actinobacteria (2 
genera, 4 species), Gammaproteobacteria (5 genera, 11 species), and Alphaproteobacteria 
(3 genera, 3 species). Information on sampling sites as well as numbers of total and of 
antimicrobial active isolates and ATUs, is given in Tables 3.1 and Table 3.2.  
 
Table 3.1 The numbers of total isolates and active isolates, as well as the number of total ATU and 
active ATU are showing for each sampling sites. The samples were collected in 23-30 m depth by 
dredging (140 cm x 30 cm) in Kattegatt, Baltic Sea on 4
th 
May 2011. 
Sampling sites Sample 
styles 
Number of bacteria ATU 
  Isolates Active Total Active 
    41 21 
A-1 30 8 13 5 
1. Baltic 1 (57°00.773 N-11°34.835 E) B-1 35 13 14 6 
 C-1 27 16 12 5 
 A-2 29 12 12 5 
2. Baltic 2 (56°58.805 N-11°35.166 E) B-2 17 9 10 5 
 C-2 31 13 14 7 
 A-3 19 13 7 2 
3. Baltic 3 (56°42.041 N-11°44.185 E) B-3 32 20 13 6 
 C-3 31 18 9 3 
Total 251 122  
 
 
In the following the term arbitrary taxonomic unit (ATU) is used as equivalent for 
species, if the sequence similarity with recognized type strains is >99.0%. The phylogenetic 
next neighbour and the corresponding type strains are indicated for each ATU. Out of the 41 
identified species, only 5 were found in all soft coral specimens or in all but 1. These are B. 
amyloliquefaciens, B. methylotrophicus, B. pumilus, B. thuringiensis and Lysinibacillus 
fusiformis. All other species were less frequent or occurred only occasionally (Table 3.2). 
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Most abundant isolates were Firmicutes, including representatives of the genera 
Bacillus (192 isolates, 17 ATUs-BA1 to BA17), Exiguobacterium (1 isolate, 1 ATU-EX), 
Paenibacillus (4 isolates, 1 ATU-PA) and Lysinibacillus (29 isolates, 4 ATUs-LY1 to 
LY4). Among 17 distinct Bacillus species isolated, most abundant species were B. 
methylotrophicus (BA8, 52 isolates) B. thuringiensis (BA16, 35 isolates) and B. 
amyloliquefaciens (BA2, 33 isolates) (Table 3.2). 
The Actinobacteria isolated in the present study belong to Blastococcus and 
Micrococcus. The genus Blastococcus is represented by a single strain (ATU-BL), which is 
closely related to the type strain of Blastococcus saxobsidens. Two isolates each of 
Micrococcus were found of the three species Micrococcus flavus (ATU-MIF), Micrococcus 
luteus (ATU-MIL), and Micrococcus yunnanensis (ATU-MIY). 
In total 18 Proteobacteria isolates were affiliated to 11 ATUs of 
Gammaproteobacteria and 3 ATUs of Alphaproteobacteria. The Gammaproteobacteria 
were identified as Pseudoalteromonas aliena (PSA1, 3 isolates), Pseudomonas peli (PSM2, 
2 isolates), Psychrobacter nivimaris (PSY2, 2 isolates), and one isolate each of 
Pseudoalteromonas prydzensis (PSA2), Pseudomonas guineae (PSM1), Psychrobacter 
alimentarius (PSY1), Psychrobacter piscatorii (PSY3), Shewanella baltica (SH1), 
Shewanella colwelliana (SH2), Shewanella putrefaciens (SH3), and Vibrio lentus (VI). 
The Alphaproteobacteria were identified as Rhizobium vignae (RH, 1 isolate), 
Labrenzia alba (LA, 1 isolate) and Sulfitobacter marinus (SU, 1 isolate). Unless otherwise 
stated, all isolates had a sequence similarity of >99.0% with the most closely related type 
strain as indicated in Tables 3.2 and Table 3.3. 
Isolates with sequence similarity less than 98.0% to the valid described species are 
assumed to be new species (Stackebrand and Ebers, 2006). A relative of Psychrobacter 
nivimaris 88/2-7
T
 (GenBank accession number AJ313425), the isolate A-1-28, had a 
similarity of 97.5% to this type strain. In addition, the isolate C-1-32 was found to be 
related to Rhizobium vignae CCBAU 05176
T 
(GenBank accession number GU128881) with 
97.6% sequence similarity). Therefore, these two isolates and also strain A-1-2B (97.8% 
sequence similarity to Lysinibacillus fusiformis DSM2898
T
) and isolate B-2-18 (97.5% 
sequence similarity to Paenibacillus lautus JCM 9073
T
) may turn out to be representatives 
of new species. 
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Table 3.2 Number of isolates affiliating to the same type strains. 
    Baltic coral samples 1 Baltic coral samples 2 
Number of isolates 
Baltic coral samples 3 
Number of isolates Total 
number 
ATUs Next related type strains 
Number of isolates 
    A-1 B-1 C-1 A-2 B-2 C-2 A-3 B-3 C-3 
BA1 Bacillus aerophilus 28K
T
 0 0 0 0 0 0 0 1 0 1 
BA2 Bacillus amyloliquefaciens NBRC15535
T
 4 3 3 4 2 1 3 7 6 33 
BA3 Bacillus cereus ATCC14579
T
 1 1 0 1 3 2 0 2 0 10 
BA4 Bacillus fusiformis NRS-350
T
 0 0 1 0 0 2 0 2 0 5 
BA5 Bacillus hwajinpoensis SW-72
T
 0 0 0 0 0 0 0 1 0 1 
BA6 Bacillus licheniformis DSM13
T
 0 5 3 4 0 0 2 4 3 21 
BA7 Bacillus megaterium IAM13418
T
 0 0 0 0 0 0 1 0 0 1 
BA8 Bacillus methylotrophicus CBMB205
T
 1 6 9 3 0 5 10 9 9 52 
BA9 Bacillus niabensis 4T19
T
 0 1 1 4 0 1 1 0 1 9 
BA10 Bacillus pumilus ATCC7061
T
 1 1 2 1 4 1 0 1 3 14 
BA11 Bacillus safensis FO-036b
T
 0 0 1 0 0 1 0 1 0 3 
BA12 Bacillus simplex DSM1321
T
 0 0 0 0 0 1 0 0 0 1 
BA13 Bacillus stratosphericus 41KF2a
T
 0 1 1 0 0 0 0 1 0 3 
BA14 Bacillus subtilis DSM10
T
 0 0 0 0 1 0 0 0 0 1 
BA15 Bacillus subtilis NRRLB-23049
T
 0 0 0 0 0 0 0 1 0 1 
BA16 Bacillus thuringiensis IAM12077
T
 8 9 1 4 1 5 0 1 6 35 
BA17 Bacillus vallismortis DSM11031
 T
 0 0 0 0 1 0 0 0 0 1 
EX Exiguobacterium oxidotolerans T-2-2
T
 1 0 0 0 0 0 0 0 0 1 
PA Paenibacillus lautu JCM9073
T
 0 1 0 0 2 0 0 0 1 4 
LY1 Lysinibacillus boronitolerans 10a
T
 4 0 0 2 1 0 0 0 0 7 
LY2 Lysinibacillus fusiformis DSM2898
T
 4 0 3 1 1 2 1 1 1 14 
LY3 Lysinibacillus sphaericus DSM28
T
 0 0 0 1 0 0 0 0 0 1 
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    Baltic coral samples 1 Baltic coral samples 2 
Number of isolates 
Baltic coral samples 3 
Number of isolates Total 
number 
ATUs Next related type strains 
Number of isolates 
    A-1 B-1 C-1 A-2 B-2 C-2 A-3 B-3 C-3 
LY4 Lysinibacillus xylanilyticus XDB9
T
 0 2 0 0 0 4 0 0 1 7 
BL Blastococcus saxobsidens DSM44509
T
 0 0 1 0 0 0 0 0 0 1 
MIF Micrococcus flavus LW4
T
 0 0 0 2 0 0 0 0 0 2 
MIL Micrococcus luteus DSM20030
T
 0 0 0 2 0 0 0 0 0 2 
MIY Micrococcus yunnanensis YIM65004
T
 0 0 0 0 0 2 0 0 0 2 
PSA1 Pseudoalteromonas aliena KMM3562
T
 0 0 0 0 0 3 0 0 0 3 
PSA2 Pseudoalteromonas prydzensis MB8-11
T
 1 0 0 0 0 0 0 0 0 1 
PSM1 Pseudomonas guineae LMG24016
T
 1 0 0 0 0 0 0 0 0 1 
PSM2 Pseudomonas peli R-20805
T
 0 2 0 0 0 0 0 0 0 2 
PSY1 Psychrobacter alimentarius JG-100
T
 1 0 0 0 0 0 0 0 0 1 
PSY2 Psychrobacter nivimaris 88/2-7
T
 2 0 0 0 0 0 0 0 0 2 
PSY3 Psychrobacter piscatorii T-3-2
T
 1 0 0 0 0 0 0 0 0 1 
SH1 Shewanella baltica NCTC10735
T
 0 1 0 0 0 0 0 0 0 1 
SH2 Shewanella colwelliana ATCC39565
T
 0 0 0 0 0 1 0 0 0 1 
SH3 Shewanella putrefaciens LMG26268
T
 0 1 0 0 0 0 0 0 0 1 
VI Vibrio lentus DSM13757
T
 0 0 0 0 1 0 0 0 0 1 
LA Labrenzia alba CECT5094
T
 0 0 0 0 0 0 1 0 0 1 
SU Sulfitobacter marinus SW-265
T
 0 1 0 0 0 0 0 0 0 1 
RH Rhizobium vignae CCBAU05176
T
 0 0 1 0 0 0 0 0 0 1 
Total 30 35 27 29 17 31 19 32 31 251 
Results 
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2. Antimicrobial activities of all isolates 
From a total of 251 isolates, ca 49% (122 isolates) exhibited antimicrobial activities 
against at least one of four indicator microorganisms. Active isolates were found in both 
GYM and BM media (44%) while only 3% active strains were reported in BM only and 2% 
in GYM only (Figure 3.1). 
 
 
Figure 3.1 Antimicrobial activity of isolates using two different media.  
  
The antimicrobial activity of all antibiotic active isolates is shown in Table 3.3. 
Antibiotic activities were found in 21 species (122 isolates) including members of the 
Firmicutes (8 ATUs, 105 isolates of Bacillus-BAs, 2 ATUs, 2 isolates of Lysinibacillus -
LY1 and LY4), Actinobacteria (1 ATU, 1 isolate of Blastococcus-BL, 3 ATUs, 6 isolates of 
Micrococcus- MIF, MIL and MIY), and Proteobacteria (7 ATUs, 8 isolates). 
Eight out of 17 distinct species of the genus Bacillus showed antimicrobial activities, 
especially all isolates of B. amyloliquefaciens (BA2) and B. methylotrophicus (BA8) 
showed antimicrobial activity against at least three of four indicator microorganisms. That 
is all of them inhibited B. subtilis, S. epidermidis and E. coli, and some of them (five 
isolates of BA2 and three isolates of BA8) in addition C. albicans. 
3% 2% 
44% 
51% 
Antimicrobial activity and media 
Active in  BM Active in GYM
Active in BM and GYM Inactive
Results 
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All Actinobacteria isolated from the present study exhibited antimicrobial activity. 
M. yunnanensis inhibited only S. epidermidis on GYM medium, while M. flavus and M. 
luteus showed antimicrobial activities against B. subtilis and S. epidermidis in both GYM 
and BM media. B. saxobsidens possessed antimicrobial activity against B. subtilis, S. 
epidermidis and E. coli only in BM medium (Table 3.3) 
Seven isolates out 15 Gammaproteobacteria displayed antimicrobial activities. They 
were assigned to P. aliena, P. nivimaris, 3 Shewanella species, and V. lentus. Bacteria P. 
aliena and V. lentus possessed antimicrobial activities against the three bacterial test 
organisms but not against the yeast C. albicans, while S. baltica had antimicrobial activities 
against the three indicator organisms but not against E. coli. 
Isolates of the 3 Shewanella species showed different activity profiles but all were 
active against B. subtilis and S. epidermidis. Notable S. baltica (SH1) inhibited in addition 
C. albicans (but only after growth in GYM medium), while S. colwelliana (SH2) (grown in 
both BM and GYM media) in addition inhibited E. coli. Inhibition of B. subtilis and S. 
epidermidis by S. putrefaciens (SH3) was found only if grown in BM medium. Among two 
isolates of P. nivimaris, one individual showed inhibition to B. subtilis only after growth in 
BM medium. Among the Alphaproteobacteria only crude extract of S. marinus (SU) 
inhibited S. epidermidis only after growth in GYM medium (Table 3.3).  
Among 122 active isolates, 119 isolates (97.5%) showed inhibition of S. 
epidermidis. Evidently, all 14 isolates of B. pumilus exhibited antimicrobial activities to S. 
epidermidis. Impressing, B. pumilus possessed antimicrobial activities favour in BM 
medium. All crude extracts of B. pumilus grown in BM medium showed inhibition to S. 
epidermidis (Table 3.3) 
A number of Bacillus strains, including the ATUs BA3, BA4, BA5, BA6, BA7, 
BA9, BA12, BA13, and BA16 displayed no antimicrobial activity. Also other Firmicutes 
including of L. fusiformis (LY2, 14 isolates) L. sphaericus (LY3, 1 isolate) P. lautus (PA, 4 
isolates) and Exiguobacterium oxidotolerans (EX, 1 isolate) were inactive to all four test 
strains. No antimicrobial activity was found as well in P. prydzensis PSA2, P. guineae 
PSM1, P. peli PSM2, P. alimentarius PSY1, and P. piscatorii PSY3. 
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 Table 3.3 Active isolates: affiliation to ATUs, isolation conditions, and antimicrobial profiles.  
*The value indicate percent (%) growth inhibition in BM/GYM media 
 
ATUs Isolates 
Media for 
Isolation 
Next relative type strain (RDP-II) 
B. 
subtilis* 
S. 
epidermidis* 
E. coli* 
C. 
albicans* 
BA1 B-3-8 TM 28
o
C B. aerophilus 28K
T
 (AJ831844: 99.2%) 0/0 86/80 0/0 0/0 
BA10 A-2-32 SW 28
0
C B. pumilus ATCC 7061
T
 (AY876289: 99.4%) 0/0 57/0 0/0 0/0 
BA10 A-1-32 TM 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.7%) 88/0 85/79 0/0 0/0 
BA10 B-2-15 SW 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.7%) 0/0 67/0 0/0 0/0 
BA10 B-2-16 TM 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.7%) 0/0 81/84 0/0 0/0 
BA10 B-2-17 TM 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.7%) 0/0 76/84 0/0 0/0 
BA10 C-2-21 TM 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.7%) 0/0 100/0 0/0 0/0 
BA10 C-1-27 SW 28
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.8%) 0/25 100/100 0/0 0/0 
BA10 C-3-34 R2A 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.8%) 58/0 90/91 0/0 0/0 
BA10 B-1-33 SW 28
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.9%) 91/0 86/84 0/0 0/0 
BA10 C-1-16 SW 28
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.9%) 93/0 96/77 0/0 0/0 
BA10 B-2-12 R2A 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.9%) 0/0 91/55 0/0 0/0 
BA10 C-3-36 R2A 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.9%) 0/0 45/0 0/0 0/0 
BA10 C-3-33 R2A 10
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.9%) 66/0 85/89 0/0 0/0 
BA10 B-3-17 TM 28
o
C B. pumilus ATCC 7061
T
 (AY876289: 99.7%) 0/0 97/97 32/42 0/0 
BA11 C-1-15 R2A 28
o
C B. safensis FO-036b
T 
(AF234854: 99.9%) 0/0 82/82 0/0 0/0 
BA11 B-3-34A SW 10
o
C B. safensis FO-036b
T 
(AF234854: 99.9%) 0/0 92/0 0/0 0/0 
BA14 B-2-7 TM 28
o
C B. subtilis DSM10
T 
(AJ276351: 99.8%) 0/0 25/86 0/0 0/0 
BA15 B-3-37 TM 10
o
C B. subtilis NRRL B-23049
T
 (AF074970: 99.9%) 0/30 100/100 0/0 0/0 
BA17 B-2-4 SW 28
o
C B. vallismortis DSM 11031
T 
(AB021198: 99.6%) 71/43 76/74 86/90 26/31 
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ATUs Isolates 
Media for 
Isolation 
Next relative type strain (RDP-II) 
B. 
subtilis* 
S. 
epidermidis* 
E. coli* 
C. 
albicans* 
BA2 A-2-4 SW 28
o
C B. amyloliquefaciens NBRC 15535
T 
(AB255669: 100%) 73/84 79/78 0/78 0/0 
BA2 A-2-23A TM 28
o
C B. amyloliquefaciens NBRC 15535
T 
(AB255669: 100%) 44/42 85/97 66/98 0/0 
BA2 C-3-39 R2A 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 100%) 79/87 83/79 87/92 0/0 
BA2 A-1-13 R2A 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.4%) 41/63 66/68 34/73 0/0 
BA2 B-2-5 TM 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.4%) 73/82 72/74 87/0 0/20 
BA2 A-3-18 TM 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.4%) 36/84 70/80 89/100 0/0 
BA2 C-2-14 R2A 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.5%) 86/94 85/90 80/90 0/0 
BA2 C-3-21 R2A 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.5%) 78/90 77/85 67/85 0/0 
BA2 C-3-20 R2A 28
o
C B. amyloliquefaciens NBRC 15535
T 
(AB255669: 99.5%) 92/96 95/87 88/100 0/0 
BA2 A-1-36 SW 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.6%) 44/72 58/71 42/80 0/0 
BA2 A-1-6A TM 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.6%) 0/79 0/76 0/86 0/0 
BA2 B-1-8 R2A 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.6%) 90/87 87/85 87/91 0/0 
BA2 B-1-11 TM 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.6%) 70/82 70/78 91/100 0/0 
BA2 B-3-1 TM 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.6%) 91/82 81/76 0/51 0/0 
BA2 C-1-11 TM 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.7%) 90/95 78/80 87/92 0/0 
BA2 A-3-17 SW 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.7%) 0/84 79/76 0/77 0/0 
BA2 B-3-6 SW 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.7%) 90/100 87/89 30/89 0/24 
BA2 B-3-33 SW 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.7%) 46/89 97/99 99/100 0/45 
BA2 C-3-23 TM 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.7%) 91/63 89/87 0/93 0/0 
BA2 C-3-30 R2A 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.7%) 74/0 82/89 86/0 0/0 
BA2 A-1-18 SW 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 84/89 80/81 73/93 0/0 
BA2 B-1-28B SW 28
o
C B. amyloliquefaciens NBRC 15535
T 
(AB255669: 99.8%) 84/87 68/76 98/100 0/0 
BA2 C-1-10 TM 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 88/80 94/99 96/100 0/33 
  
31 
 
ATUs Isolates 
Media for 
Isolation 
Next relative type strain (RDP-II) 
B. 
subtilis* 
S. 
epidermidis* 
E. coli* 
C. 
albicans* 
BA2 A-2-5 SW 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 59/88 85/89 95/100 0/0 
BA2 A-2-14 R2A 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 39/68 89/99 88/99 0/0 
BA2 B-2-2 R2A 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 84/0 88/83 89/91 0/0 
BA2 A-3-13 SW 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 87/88 81/83 0/85 0/0 
BA2 B-3-12 R2A 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 91/92 84/87 94/93 0/0 
BA2 B-3-21 R2A 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 53/90 96/99 97/100 0/0 
BA2 B-3-16 SW 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 89/91 83/85 83/93 0/0 
BA2 B-3-32 R2A 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 84/91 94/100 36/100 0/0 
BA2 C-3-35 R2A 10
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.8%) 69/86 82/88 77/81 0/0 
BA2 C-1-9 R2A 28
o
C B. amyloliquefaciens NBRC 15535
T
 (AB255669: 99.9%) 43/28 66/69 80/76 0/0 
BA8 B-3-26 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 100%) 89/88 83/77 91/91 0/0 
BA8 C-1-17 SW 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.5%) 87/93 79/83 89/89 0/0 
BA8 C-2-10 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.5%) 70/82 71/80 91/100 0/0 
BA8 B-3-36 TM 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.5%) 92/97 88/100 84/100 0/0 
BA8 C-2-5A TM 28
o
C B. methylotrophicus CBMB 205
T 
(EU194897: 99.6%) 87/86 81/83 82/80 0/0 
BA8 C-2-9 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.6%) 87/85 80/80 93/91 0/0 
BA8 B-3-18 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.6%) 67/93 57/88 97/100 0/0 
BA8 C-2-32 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.6%) 80/84 89/95 97/99 0/0 
BA8 A-1-34 SW 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 64/85 78/84 87/92 0/0 
BA8 B-1-13 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 59/51 85/80 0/87 0/0 
BA8 B-1-27 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 79/80 66/77 35/100 0/0 
BA8 B-1-31 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 86/88 77/82 0/46 0/0 
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ATUs Isolates 
Media for 
Isolation 
Next relative type strain (RDP-II) 
B. 
subtilis* 
S. 
epidermidis* 
E. coli* 
C. 
albicans* 
BA8 C-1-7 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 32/91 90/93 95/100 0/0 
BA8 C-1-21 R2A 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 36/33 74/71 93/82 0/0 
BA8 C-1-22 R2A 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 34/89 76/80 88/90 0/0 
BA8 C-1-25 TM 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 73/85 62/71 92/91 0/0 
BA8 C-1-5 TM 28
o
C B. methylotrophicus CBMB 205
T 
(EU194897: 99.7%) 90/0 81/81 0/61 0/0 
BA8 A-2-2 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 77/87 82/90 99/100 0/0 
BA8 C-2-5B TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 88/95 89/91 83/78 0/0 
BA8 A-3-3 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 0/91 75/82 80/95 0/0 
BA8 A-3-6C SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 72/90 95/96 99/99 0/0 
BA8 A-3-22 TM 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 62/78 68/77 70/85 0/0 
BA8 A-3-23A R2A 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 82/86 83/85 87/90 0/0 
BA8 A-3-23B R2A 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 86/77 74/75 89/80 36/0 
BA8 A-3-6A SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 45/72 82/85 98/99 0/0 
BA8 A-3-6B SW 28
o
C B. methylotrophicus CBMB205
T
 (EU194897: 99.7%) 66/84 68/73 92/100 0/0 
BA8 A-3-8 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 51/96 89/99 70/100 0/0 
BA8 B-3-24 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 48/80 71/74 96/100 0/49 
BA8 B-3-13 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 37/50 81/83 99/99 0/0 
BA8 B-3-23 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 66/90 81/81 0/87 0/0 
BA8 C-3-14 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.7%) 79/74 83/82 0/91 0/0 
BA8 B-1-14 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 60/88 78/85 51/100 0/0 
BA8 C-1-12 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 72/0 75/73 45/64 0/0 
BA8 C-1-13 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 0/94 76/85 0/93 0/0 
BA8 C-1-24 R2A 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 88/83 100/82 97/92 0/0 
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ATUs Isolates 
Media for 
Isolation 
Next relative type strain (RDP-II) 
B. 
subtilis* 
S. 
epidermidis* 
E. coli* 
C. 
albicans* 
BA8 A-2-23B TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 0/47 71/80 58/99 0/28 
BA8 A-3-2 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 57/87 81/82 0/83 0/0 
BA8 A-3-7B TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 22/0 88/88 100/100 0/0 
BA8 B-3-2 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 76/90 91/99 95/100 0/0 
BA8 B-3-28 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 73/79 73/86 75/99 0/0 
BA8 B-3-20 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 37/86 63/89 95/99 0/0 
BA8 C-3-2 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 24/42 84/81 0/92 0/0 
BA8 C-3-4 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 88/82 82/85 89/93 0/0 
BA8 C-3-6 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 42/79 83/91 81/93 0/0 
BA8 C-3-10 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 86/88 80/82 89/91 0/0 
BA8 C-3-19 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 72/61 80/77 0/91 0/0 
BA8 C-3-7 TM 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 74/68 81/87 64/94 0/0 
BA8 C-3-9 R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 66/0 80/87 91/82 0/0 
BA8 C-3-17 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.8%) 98/91 93/86 91/91 0/0 
BA8 B-1-28A R2A 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.9%) 80/79 85/83 0/88 0/0 
BA8 B-1-30 SW 28
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.9%) 82/89 79/84 0/82 0/0 
BA8 A-2-17 R2A 10
o
C B. methylotrophicus CBMB 205
T
 (EU194897: 99.9%) 75/71 86/88 94/100 0/0 
LY1 A-1-40B TM 28
o
C L. boronitolerans 10aT (AB199591 : 98.6%) 0/0 0/0 0/0 34/42 
LY4 C-2-29 TM 10
o
C L. xylanilyticus XDB9
T
 (FJ477040: 99.0%) 0/0 0/0 0/0 57/68 
BL C-1-31 BS 28
o
C B. saxobsidens DSM 44509
T
 (FN600641: 98.8%) 50/0 94/0 86/0 0/0 
MIF A-2-19A SW 28
o
C M. flavus LW4
T
 (DQ491453: 99.2%) 0/0 35/60 0/0 0/0 
MIF A-2-28 SW 10
o
C M. flavus LW4
T
 (DQ491453: 99.3%) 0/0 30/68 0/0 0/0 
MIL A-2-7 TM 28
o
C M. luteus DSM 20030
T
 (AJ536198: 99.7%) 0/0 60/74 0/0 0/0 
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ATUs Isolates 
Media for 
Isolation 
Next relative type strain (RDP-II) 
B. 
subtilis* 
S. 
epidermidis* 
E. coli* 
C. 
albicans* 
MIL A-2-19B SW 28
o
C M. luteus DSM 20030
T
 (AJ536198: 99.8%) 0/0 60/62 0/0 0/0 
MIY C-2-28 TM 10
o
C M. yunnanensis YIM 65004
T
 (FJ214355: 99.4%) 0/0 0/97 0/35 0/0 
MIY C-2-27 TM 10
o
C M. yunnanensis YIM 65004
T
 (FJ214355: 99.9%) 0/0 0/83 0/0 0/0 
PSA1 C-2-1 R2A 10
o
C P. aliena KMM 3562
T
 (AY387858: 99.2%) 72/69 78/61 0/22 0/0 
PSA1 C-2-19 SW 10
o
C P. aliena KMM 3562
T
 (AY387858: 99.3%) 76/76 56/29 0/0 0/0 
PSY2 A-1-30 SW 10
o
C P. nivimaris 88/2-7
T
 (AJ313425: 99.0%) 31/0 0/0 0/0 0/0 
SH1 B-1-21 R2A 10
o
C S. baltica NCTC 10735
T
 (AJ000214: 98.5%) 0/67 0/41 0/0 0/32 
SH2 C-2-3 R2A 10
o
C S. colwelliana ATCC 39565
T
 (AY653177: 99.9%) 74/62 84/88 89/89 0/0 
SH3 B-1-22 R2A 10
o
C S. putrefaciens LMG 26268
T
 (X81623: 99.0%) 91/0 92/0 0/0 0/0 
SU B-1-18 BS 10
o
C S. marinus SW-265
T
 (DQ683726: 99.7%) 0/0 0/88 0/0 0/0 
VI B-2-1 R2A 10
o
C V. lentus DSM 13757
T
 (AJ278881: 98.8%) 79/00 85/87 90/84 0/0 
Results  
 
35 
 
3. Chemical substances produced by soft coral-associated bacteria 
Based on the results of antimicrobial tests and chemical analysis in the screening 
experiments, four soft coral associated isolates were selected for scale-up of the production 
of metabolites. These are Lysinibacillus sp. strain C-2-29, Bacillus sp. strain H-6, 
Micrococcus sp. strain A-2-28, and Bacillus sp. strain C-1-10. 
The chemical analysis from HPLC-DAD-MS of crude extract of strain C-2-29 (next 
relative Lysinibacillus xylanilyticus XDB9
T
) showed that this strain produced at least 8 
compounds present in cells grown in both of the screening media. Three out of these 8 were 
present in large amounts and showed good UV signals. The crude extract also showed 
inhibition only against C. albicans in both GYM and BM media. Species of the new genus 
Lysinibacillus were transferred from Bacillus (Ahmed et al. 2007). This species was not 
reported for bioactive compound producer so far. The strain L. xylanilyticus XDB9
T 
was 
reported to be a xylan-degrading bacterium isolated from forest humus (Lee et al. 2010). 
Most abundant isolates from this study were members of the genus Bacillus. Marine 
Bacillus sp. strains also were common producers of bioactive compounds. The strain H-6 
(next relative Bacillus pumilus ATCC7061
T
) was isolated from soft coral A. digitatum from 
Helgoland in the North Sea and showed strong antimicrobial activity against S. epidermidis 
in both media used for the screening experiments. The strain H-6 produced different 
compounds in two different screening media. Two of these compounds might be unknown. 
Most isolates closely related to B. pumilus ATCC7061
T
 as next relative showed rather weak 
UV signals. The best UV signals were shown by strain H-6 and therefore this strain was 
chosen for further studies. 
Micrococcus sp. was the most common bacterium among the isolates from the soft 
corals. Only few investigations of natural compounds from Micrococcus sp. were reported 
previously (Palomo et al. 2013). In this study, Micrococcus sp. strain A-2-28 (next relative 
Micrococcus flavus LW4
T
) was further considered for large scale cultivation, chemical 
analyses, and biological activities. Crude extract of the strain A-2-28 inhibited only S. 
epidermidis. The metabolites of the strain A-2-28 were completely different to those of the 
selected strains of Bacillus spp. strain C-1-10 and strain H-6 which also inhibited only S. 
epidermidis. The strain A-2-28 produced a number of compounds with three main 
compounds and good UV signals.  
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Unlike strain H-6, crude extracts of the strain C-1-10 (next relative Bacillus 
amyloliquefaciens NBRC15535
T
) showed inhibition of all four test organisms. In addition, 
the chemical analysis revealed that this strain produced a greater number of metabolites, 
some of which are known according to the DNPs and others could so far not be identified. 
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3.1 Lysinibacillus sp. C-2-29 
3.1.1 Origin, cultivation and identification of the strain C-2-29  
The strain C-2-29 was isolated from soft coral A. digitatum Baltic 2 at 10
o
C in TM 
medium, and was identified as Lysinibacillus sp., because the sequence of the 16S rRNA 
gene showed 99.0% similarity with Lysinibacillus xylanilyticus XDB9
T 
(GenBank accession 
number FJ477040), 98.9% similarity with Lysinibacillus boronitolerans 10a
T
 (GenBank 
accession number AB199591), and 98.3% sequence similarity with Lysinibacillus 
fusiformis DSM 2898T
T 
(GenBank accession number AJ310083), which are derived from 
the  RDP-II (Cole et al. 2014). 
Based on a taxonomic study, especially in cell wall peptidoglycan structures, the 
genus Lysinibacillus was proposed by Ahmed et al. (2007) and several species were 
transferred from the genus Bacillus to this new genus. Today it consists of 5 species with 
validly published names Lysinibacillus boronitolerans, Lysinibacillus fusiformis, 
Lysinibacillus sphaericus (Ahmed et al. 2007), Lysinibacillus parxiboronicapiens (Miwa et 
al. 2009), and Lysinibacillus xylanilyticus (Lee et al. 2010). 
 
3.1.2 Cultivation and extraction of the strain C-2-29  
The screening approach using 100 ml GYM or BM medium, respectively, revealed 
the detection of 8 compounds in both screening media, with enhanced production in GYM 
medium. In a second step the production was tested using a cultivation volume of 1 L. 
After 4 days cultivation, 100 ml broth culture was harvested from 1 L flask culture, 
and centrifuged (8.000 g, 4
o
C). Then the bacterial cells were extracted with 100 ml of 
methanol, and the supernatant was extracted with 100 ml of ethyl acetate. The extracts were 
concentrated and injected in HPLC-DAD-MS for analysis of the metabolite profiles in 
supernatant or bacterial cells, respectively. Three out of 8 compounds produced by this 
strain were found both in supernatant (extracted with ethyl acetate) and bacterial cells 
(extracted with methanol). Because the production of those three compounds was 
confirmed, a cultivation volume of 40 L in GYM medium was used for extraction and 
purification of large amounts. Culture broth (total 40 L) was extracted with ethyl acetate. 
The crude extract was tested against C. albicans and purified using HPLC because of its 
inhibitory activity. 
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3.1.3 Compound purification  
Four grams of crude extract were separated with VWR International LaPrep system 
monitoring absorption at a wavelength of 210 nm with a gradient 0 min 15% B, 26 min 86% 
B, 27 min 100% B, flow 100 ml/min. 10 mg of fraction 1, 30 mg of fraction 2, and 5 mg of 
fraction 3 were harvested.  
To purify compound 1, semi preparation of 10 mg of fraction 1 was carried out on 
Merck Hitachi Elite LaChrom system 1 with a gradient from 20% B at 0 min increasing to 
55% B at 15 min, to 100% B from 27 min to 28 min, flow 15 ml/min. The compound 1 
(MW 223) was eluted at 10 min, and yielded 2 mg. 
30 mg of pure compound 3 was harvested from the fraction 2 by preparation of 4 
grams of crude extract using VWR International LaPrep system. 
For purification of compound 5, 5 mg of fraction 3 was applied on Merck Hitachi 
Elite LaChrom system 2 with a gradient from 30% B at 0 min increasing to 100% B at 25 
min, flow 14 ml/min and yielded 0.8 mg of purified compound 5 (MW 467) at 19 min. 
 
3.1.4 Metabolic profile 
The strain C-2-29 produced at least 8 compounds which could be identified by the 
mass and UV maxima (Table 3.4, Figure 3.2, Figure 3.3). The same compounds were 
produced in both 100 ml volume cultures in GYM and BM media. 
The compounds 1-8 were found in both 100 ml cultures in GYM and BM media 
(Figure 3.2, Figure 3.3). The compounds 1 (MW 223) and 3 (MW 338) were found as main 
peaks in 100 ml cultures in GYM and BM media and also in 1 L cultures in GYM medium. 
The compound 2 (MW 299), compound 4 (MW 283), and compound 6 (MW 253) were 
present in very low amounts in both 100 ml and 1 L cultures with weak UV signals. The 
compound 5 (MW 467) was found in low amounts but demonstrated rather good UV signals 
in the 100 ml volume cultures and the 1 L cultures. Peak 7 (MW 456, MW 148) and 
compound 8 (MW 643) were found only in the 100 ml cultures. Therefore, compounds 2, 4, 
6, peak 7, and compound 8 could not be purified and further analysed.  
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Table 3.4 Chemical profiles and purified compounds of the strain C-2-29. 
CNo/ 
Peak 
Media MW Rt 
[min] 
UV [nm] 
maxima 
CP/yield CN/comment 
1 
GYM/100 ml 
BM/100 ml 
GYM/1 L 
223 3.2 224, 275 
Purification;      
2 mg 
Maybe a 
deacetylanisomycin 
2 
GYM/100 ml 
BM/100 ml 
GYM/1 L 
299 3.9 219, 281 
No 
purification 
Low amounts 
3 
GYM/100 ml 
BM/100 ml 
GYM/1 L 
338 4.2 
224, 276, 
325 
Purification;    
30 mg 
2,5-bis (3-
indolylmethyl) 
pyrazine 
4 
GYM/100 ml 
BM/100 ml 
GYM/1 L 
283 4.5 223, 276 
No 
purification 
Not present after 
preparation 
5 
GYM/100 ml 
BM/100 ml 
GYM/1 L 
467 4.7 227, 279 
Purification;   
0.8 mg 
Unknown     
Maybe new 
6 
GYM/100 ml 
BM/100 ml 
GYM/1 L 
253 4.9 
216, 266, 
273 
No 
purification 
Not present after 
preparation 
7* 
GYM/100 ml 
BM/100 ml 
456 
148 
5.1-5.3 
223, 266, 
273 
No 
purification 
Not present in        
1 L cultures 
8 
GYM/100 ml 
BM/100 ml 
643 5.4 
224, 267, 
277 
No 
purification 
Not present in        
1 L cultures 
* Peak 7 consists of 2 compounds (MW 456 and MW 148), CNo: compound number; MW: 
molecular weight; Rt: retention time; CP: compound purification; CN: compound name. 
 
 
Figure 3.2 UV spectrums of C-2-29 in GYM medium (100 ml volume). 
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Figure 3.3 UV spectrums of C-2-29 in BM medium (100 ml volume). 
 
Compounds 1, 3 and 5 were isolated from 1 L cultures from strain C-2-29 and 
purified (Table 3.4, Figure 3.4). By comparing the data from literature it was noted that the 
compound 1 (MW 223) may be deacetylanisomycin. The compound 3 was identified as 2,5-
bis (3-indolylmethyl) pyrazine and the compound 5 was an unidentified or new compound. 
 
 
Figure 3.4 UV spectrums of C-2-29 in 1 L cultures in GYM medium. 
 
Searching of data from DNPs it was found that compound 1 (MW 223, UV max 
224, 275) might be a deacetylanisomycin (MW 223, UV max 223, 276) that was found from 
Streptomyces sp. SA (Sobin and Tanner, 1954) because of matching of UV maxima and 
molecular weight as well. The structure elucidation of compound 1 is in progress. 
The known compound 3 (MW 338) was identified as 2,5-bis (3-indolylmethyl) 
pyrazine (Figure 3.5), which was first isolated from Cytophaga sp. strain AM 13.1 from the 
North Sea (Shaaban et al. 2002). 
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Figure 3.5 Structure of the compound 3 which is 2,5-bis (3-indolylmethyl) pyrazine. 
 
Also by searching data from DNPs, there were 4 hits for compound 5 (MW 467, UV 
227, 279) which were not matching in biological sources. It inferred that there are different 
compounds which had the same MW but were not produced by Lysinibacillus sp. strains. 
For example, marinamycin was isolated from Streptomyces mariensis (Soeda, 1959; Soeda 
and Mitoni, 1962), and considered similar to compound 5 because of sharing of molecular 
weight (467) and UV maxima (220, 278). Marinamycin was an antitumor substance (Soeda, 
1959; Soeda and Mitoni, 1962). 
The other three hits for the compound 5 were the antibiotic K252a (MW 467, UV 
max 227, 249, 264, 280, 290, 320 334, 335), cyclopiamine A (MW 467, UV max 230, 261, 
344), cyclopiamine B (MW 467, UV max 232, 260, 345), and laxiracemosin D (MW 467, 
UV max 208, 220, 262, 306). Antibiotic K252a was isolated from Nocardiopsis sp. and 
Streptomyces longisporoflavus R19, and showed protein kinase C and phosphorylase kinase 
inhibition, calmodulin inhibitor, antiallergic agent, and vasorelaxant (Kase et al. 1986). 
Cyclopiamine A and B were isolated from Penicillium cyclopium. This compound was toxic 
(Bond et al. 1979). Laxiracemosin D was isolated from plant Dysoxylum laxiracemosum, it 
possessed cytotoxic activity against human myeloid leukemia HL-60 at IC50=6.8µM (Zhang 
et al. 2010). The structure elucidation of compound 5 is in progress. 
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3.1.5 Bioactivities of the isolated compounds 
The biological activities of three purified compounds are shown in Table 3.5. The 
compound 1 and 5 were inactive in all tests, whilst the compound 3 showed weak inhibition 
of S. aureus MRSA with 29.0%.  
 
Table 3.5 Bioactivities assays of pure compounds isolated from C-2-29. 
Compounds Antibacterial Antifungal Cytotoxic Enzyme inhibition 
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1 (MW 223) - - - - - - - - - - - - - - - 
3 (MW 338)  - - 29 - - - - - - - - - - - - 
5 (MW 467)  - - - -  -  - -  -  - - -  - -  -  - 
 The numbers indicate the percentage of inhibition. (-) indicate negative results. 
 
As mentioned above, the known compound 3 (MW 338) was identified as 2,5-bis (3-
indolylmethyl) pyrazine. This compound has been reported to be an inactive compound to 
three microalgae, the fungus Mucor miehei, the yeast C. albicans and the bacteria S. aureus, 
B. subtilis, E. coli and Streptomyces viriochromogenes (Shaaban et al. 2002). The 
compound 3 isolated from Lysinibacillus sp. strain C-2-29 in this study was inactive to 
applied biological tests beside a very weak activity against S. aureus MRSA. 
 
3.1.6 Discussion  
Two main compounds were produced from the strain Lysinibacillus sp. C-2-29, 
compound 1 (MW 223) and compound 3 (MW 338) in both 100 ml volume cultures in 
GYM and BM media. They were found in both supernatant and bacterial cell extracts. The 
crude extract from 1 L cultures in GYM medium had 2 main compounds (1, 3) (Figure 3.4) 
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and showed inhibition of C. albicans in addition. This inferred that the compound 
responded for C. albicans inhibition existed in crude extract of 1 L cultures. It could be 
none of the three purified compounds, because these were inactive to C. albicans (Table 
3.5). However, it is proposed that compound 1 is deacetylanisomycin, a hydrolysed product 
of anisomycin. Anisomycin (Figure 3.6-I), which inhibited C. albicans (Lynch et al. 1954) 
was hydrolysed to deacetylanisomycin during cultivation or extraction procedure (Figure 
3.6-II). Success of isolation of deacetylanisomycin (MW 223, C12H17NO3) instead of 
anisomycin (MW 265, C14H19NO4) after partition chromatography was more usually than 
isolation of anisomycin (Butler, 1966). Anisomycin or flagecidin antibiotic was first 
isolated from a mixed fermentation of two species of Streptomyces sp. as an antiprotozoan 
agent (Sobin and Tanner, 1954). Anisomycin was replaced by nystatin as an antifungal 
agent in Thayer-Martin medium (Martin and Lewis, 1977). This medium was used 
specificity to isolate the Gram-negative human pathogenic bacteria Neisseria gonorrhoeae 
from specimens containing a mixture of bacteria and fungi (Granato et al. 1980). Now 
anisomycin is a well-known compound to be added to Martin-Lewis medium to inhibit C. 
albicans. 
 
Figure 3.6 Structure of anisomycin (I) and deacetylanisomycin (II). 
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3.2 Bacillus sp. H-6 
3.2.1 Origin, cultivation and identification of the strain H-6 
The strain H-6 was isolated from the soft coral A. digitatum in Helgoland (North 
Sea, GPS 54
o10, 405‟N, 7o52, 955‟E). All sampling procedures were displayed in Material 
and Methods part 1. In summary, soft corals were collected by SCUBA diving at ca. 10 m 
depth, sub-sampled in laboratory at Alfred Wegener Institute (AWI) at Helgoland and 
bacterial cultivation was carried out at GEOMAR. The strain H-6 was isolated from coral 
tissues in R2A medium.  
Analysis of the 16S rRNA gene sequence of the strain H-6 from RDP-II (Cole et al. 
2014) showed that this strain was a Bacillus sp. and shared 99.8% sequence similarity with 
Bacillus pumilus ATCC7061
T 
(GenBank accession number AY876289), 99.6% sequence 
similarity with Bacillus safensis FO-036b
T 
(GenBank accession number AF234854) and 
99.3% sequence similarity with both Bacillus aerophilus 28K
T 
(GenBank accession number 
AJ831844) and Bacillus stratosphericus 41KF2a
T
 (GenBank accession number AJ831841). 
 
3.2.2 Cultivation and extraction of the strain H-6 
Chemical analyses of metabolites of strain H-6 produced the same compounds but in 
different amounts in both screening media. There were three interesting compounds which 
were found in BM medium in large amounts. Therefore, a total of 20 L of cultures were 
extracted and used for preparation. 
 
3.2.3 Compound purification  
The 2.3 grams of crude extract obtained from 20 L culture were separated with 
VWR International LaPrep system monitoring absorption at a wavelength of 210 nm with 
gradient 0 min 15% B, 26 min 86% B, 27 min 100% B, flow 100 ml/min and yielded a total 
of 60 mg fraction 1 (mix of compounds 1, 2, 4 and 5) and a total of 100 mg fraction 2 (mix 
of compounds 3, 4 and 5), 7.7 mg of fraction 3 (compound 7), and 30 mg of fraction 4 
(compound 8). Compound 6 (MW 389) was not found in any fraction because this 
compound was not produced in 1 L cultures. 
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Compound 5 was present in large amounts in fraction 2 and in low amounts in 
fraction 1, this compound also was considered as an unknown compound. Compounds 1 
and 2 were main components of fraction 1 and both compounds were known compounds. 
The fraction 1 and fraction 2 were purified in the semi-preparative-Merck Hitachi Elite 
LaChrom system 1 for isolation of compound 5 (MW 476). However, no purification could 
be achieved, which might be due to the same UV maxima of different compounds contained 
in the fractions and instability of the compound 5 in addition (see discussion).   
The fraction 4 consisted of compound 8 (MW 1035) and an additional peak of two 
compounds (MW 835, 1049) which was found only in 1 L cultures, this fraction was 
separated with the semi preparative-Merck Hitachi Elite LaChrom system 1 to purify 
compound 8 (MW 1035) which presented as a main compound in fraction but this work was 
not successful due to overlap of the mass (MW 1035 and MW 1049) and UV maxima at the 
same retention time. 
The fraction 3 yielded 7.7 mg and contained only compound 7 with a rather good 
UV signal, so that this compound was purified with semi preparation and yielded 2.5 mg. 
Semi preparation of 7.7 mg of compound 7 (MW 444) was carried out with a semi 
preparative HPLC on Merck Hitachi Elite LaChrom system 2 with a gradient from 30% B 
at 0 min increasing to 80% B at 15 min, to 100% B from 27 min to 27.5 min, flow 14 
ml/min, yielded 2.5 mg of purified compound 7 at 13 min.  
 
3.2.4 Metabolic profile 
The main metabolites of strain H-6 are listed in Table 3.6. Strain H-6 produced at 
least 8 compounds both in 100 ml volume cultures in GYM and BM media. Compound 1 
(MW 423) and compound 3 (MW 438) were main peaks in 100 ml volume cultures in GYM 
medium. Other compounds (compound 2, 4, 5, 6, 7 and 8) were presented in low amounts 
(Table 3.6, Figure 3.7).The compound 1 (identified as amicoumacin A), the compound 2 
(identified as bacilosarcin B), the compound 6 (considered to be AI-77F), and the 
compound 8 (a cyclic peptide, see part 3.4) possessed the same molecular weight, UV 
maxima as well as biological sources with data in the literature. Those four compounds 
might be noted as known compounds. Other compounds from H-6 were not identified. 
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Table 3.6 Chemical profiles and purified compounds of the strain H-6. 
 
CNo 
Peak 
Media MW 
Rt 
[min] 
UV [nm] 
maxima 
CP/yield CN/comment 
1 
GYM/100 ml 
BM/100 ml 
BM/1 L 
423 2.6 
212, 248, 
315 
No 
purification 
Maybe a 
amicoumacin 
A 
2 
GYM/100 ml 
BM/100 ml 
BM/1 L 
493 2.7 
212, 249, 
315 
No 
purification 
Maybe a 
bacilosarcin B 
3 
GYM/100 ml 
BM/100 ml 
438 2.9 
212, 248, 
315 
No 
purification 
Unknown 
Maybe new 
4 
GYM/100 ml 
BM/100 ml 
508 3.1 
212, 251, 
315 
No 
purification 
Unknown 
Maybe new 
5 
GYM/100 ml 
BM/100 ml 
BM/1 L 
476 3.2 
212, 248, 
315 
Not 
successfully 
purified 
Unknown 
Maybe new  
6 
GYM/100 ml 
BM/100 ml 
389 3.5 
213, 246, 
311 
No 
purification 
Maybe a       
AI- 77F 
7 
GYM/100 ml 
BM/100 ml 
BM/1 L 
444 4.5 225 
Purification;  
2.5 mg 
Unknown 
Maybe new 
8* 
GYM/100 ml 
BM/100 ml 
BM/1 L 
1035 
835 
1049 
6.4 224, 278 
No 
purification 
Maybe 
bacillopeptins  
* Peak 8 consists of 3 compounds (MW 1035, MW 835, and MW 1049); CNo: compound number; 
MW: molecular weight; Rt: retention time; CP: compound purification; CN: compound name. 
 
The compounds 1 (MW 423) and 2 (MW 493) were main compounds in 100 ml 
volume cultures in BM medium. In addition, the compounds 3 (MW 438), 4 (MW 508), and 
5 (MW 476) were found. Other compounds (6, 7 and 8) were also found in 100 ml volume 
cultures in BM medium with low amounts according to mass detection (Figure 3.7).  
The strain H-6 was scaled up in 1 L in BM medium for isolating of compounds 3, 4 
and 5. However, the strain H-6 produced 5 main compounds compound 1, 2, 5, 7, and 8, but 
no compounds 3, 4, and 6 in the 1 L cultures. In addition, a group of compounds with MW 
835 and MW 1049 were observed in 1 L cultures in BM medium. Both compounds shared 
the same UV maxima to compound 8 (MW 1035) and showed very close retention time also 
(Table 3.6, Figure 3.8).  
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Figure 3.7 Chemical profiles of H-6 in 100 ml cultures. Red-mass, blue-UV. 
 
 
Figure 3.8 Chemical profiles of H-6 in 1 L cultures in BM medium. Red-mass, blue-UV. 
 
The compounds 5 and 7 were regarded as unknown compound found from 1 L 
cultures of strain H-6 in BM medium. Therefore, these compounds were purified. 
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3.2.5 Bioactivities of the isolated compounds 
The compound 7 (MW 444) was found in 100 ml volume cultures at low amounts 
but was main mass peak in 1 L cultures with good UV signals (Table 3.6, Figure 3.8). This 
compound was successfully isolated. The structure elucidation is in progress. This 
compound did not show any antibacterial activities and did not possess any cytotoxic and 
enzyme inhibition activities. 
 
3.2.6 Discussion  
By comparison of molecular weight, UV maxima and biological sources from 
DNPs, the compound 1 (MW 423, UV max 212, 248, 315) may be an amicoumacin A (MW 
423, UV max 216, 245, 315) which was first isolated from B. pumilus (Itoh et al. 1981). 
Compound 1 was the main compound of strain H-6 in 100 ml volume cultures in GYM and 
BM media. Crude extract of strain H-6 of 100 ml broth cultures showed 100% inhibition of 
S. epidermidis. The compound 1 might be responsible for S. epidermidis inhibition. It is 
evident that amicoumacin A (Figure 3.9) produced by B. pumilus BN-103 inhibited S. 
epidermidis ATCC 14990 at very low concentration (0.2 mcg/ml) (Itoh et al. 1981 and 
1982). 
 
Figure 3. 9 Structure of amicoumacin A from Bacillus sp. 
 
Properties of compound 2 (MW 493, UV max 212, 249, 315) are most similar to 
bacilosarcin B (MW 493, UV max 206, 247, 315) which was produced by B. subtilis strain 
TP-B0611 (Azumi et al. 2008). Bacilosarcin B is a member of the amicoumacin group. 
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Amicoumacin A (C20H29N3O7) and bacilosarcin B (Figure 3.10) have an amide functional 
group at C-12', exhibited antibacterial activities against S. aureus, and possessed 
cytotoxicity (IC50=33.6 µM) against the human HeLa cells (Li et al. 2012).  
 
Figure 3.10 Structure of bacilosarcin B from B. subtilis TP-B0611 (Azumi et al. 2008). 
 
There were several hits for the compound 3 (MW 438) which was found mainly in 
GYM medium (in 100 ml volume), and 10 hits for the compound 4 (MW 508). However, 
they did not match in UV maxima and biological sources. There were two hits for the 
compound 5 (MW 476) from DNPs by searching of the biological sources and molecular 
weight. It was tetraprenyl-β-curcumene (MW 476, C35H35) which was produced by marine 
B. subtilis (Böröczky et al. 2006, Kontnik et al. 2008). However, there was no UV 
information available. Also no UV spectrum was available for the second compound 
trihexocin (MW 476). This antifungal antibiotic was isolated from a soil Bacillus sp. strain 
SY-414 (Shin and Yoo, 1995). By searching of molecular weight and UV maxima from 
DNPs there were 11 hits for compound 5 (MW 476), 23 hits for compound 7 (MW 444, UV 
max 225). But all hits did not perfectly match.  
The compound 6 (MW 389, UV max 246, 311) was found only in 100 ml both 
cultures in GYM and BM media (Figure 3.7). This compound was regarded as AI-77F (MW 
389, UV max 245, 312) which was isolated from soil B. pumilus AI-77 (Shimojima et al. 
1982a). The substance AI-77F was not clearly approved as being of biogenetic origin or 
produced by degradation (Shimojima et al. 1982b). In addition, this substance was reported 
as inactive against B. subtilis and S. aureus (Li et al. 2012). 
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At first point of view, compounds 3 (MW 438), 4 (MW 508), and 5 (MW 476) 
might be interesting compounds. However, they shared the same UV maxima and had 
retention times very similar to the compound 1, and 2, (range Rt at 2.9, 3.1, and 3.2 min). 
That was the big problem for separation by HPLC-UV method. Although the fractions 1, 2 
were attempted to be separated with semi-preparative HPLC, the compounds could not be 
purified. 
The compound 5 was identified with base peak chromatogram (BPC) analysis and 
was clearly visible in individual fractions next after of crude extract preparation (Figure 
3.11).  
 
Figure 3.11 The presentation of the compound 5 (MW 476) in fractions after preparation. 
 
The fraction 2 included compound 5 is shown in Figure 3.12. The fraction 2 is 
illustrated in sky colour and the presence of compound 5 is confirmed by extracted ion 
chromatogram analysis with red colour. The compound 5 was found as main component of 
the fraction 2. After 2 and 4 weeks storing, the compound 5 disappeared. Instead compound 
3 (MW 438), compound 4 (MW 508), and unidentified mass 566 were observed (Figure 
3.12). 
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Figure 3.12 The fraction 2 (sky line), compound 5 (MW 476-red line), after preparation 2 weeks 
and 4 weeks (black and blue) consists of compound 3 (MW 438) and compound 4 (MW 508). 
 
Significantly, the compound 3 (MW 438), and the compound 4 (MW 508) were not 
found in crude extract of 1 L cultures in BM medium (Figure 3.8) but in the mixture of 
fraction 2 after preparation and 2 weeks storage (Figure 3.12). Consequently, the compound 
5 might be an unstable compound because the mass of this compound changed by time.  
Finding of the compound 3 (MW 438) in the fraction 2 after preparation of crude 
extract of 1 L cultures in BM medium was unexpected, because of its absence in crude 
extract. It is suggested that this compound was might be a product of degradation of other 
compounds. It was thought that it was impossible to isolate unstable compounds because of 
time consuming. One other obstacle was that most of the compounds produced by this strain 
have very similar UV spectra and retention times. Therefore, this strain H-6 is a potential 
candidate for more detailed studies. 
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3.3 Micrococcus sp. A-2-28 
3.3.1 Origin, cultivation and identification of the strain A-2-28 
The strain A-2-28 was isolated from soft coral A. digitatum Baltic 2 at 10
o
C in SW 
medium and identified as Micrococcus sp., because analysis of 16S rRNA gene sequence 
showed 99.3% sequence similarity with Micrococcus flavus LW4
T
 (GenBank accession 
number DQ491453), 98.6% similarity with Micrococcus yunnanensis YIM65004
T
 
(GenBank accession number FJ214355), and 98.5% sequence similarity with Micrococcus 
luteus DSM 20030
T 
(GenBank accession number AJ310083) which are derived from the 
“Ribosomal Database Project” (Cole et al. 2014). 
 
3.3.2 Cultivation and extraction of the strain A-2-28 
Cultivation of strain A-2-28 was scaled up in 1 L in GYM medium. The 100 ml of 
broth culture was extracted after 2, 3 and 4 days, applied to HPLC-DAD-MS to check the 
presence of three main compounds which were identified in screening media. The identified 
metabolites in 1 L cultures disappeared after 4 days cultivation. Therefore, a total of 12 L 
broth was harvested after 72 h cultivations, extracted with ethyl acetate and separated with 
semi HPLC. 
 
3.3.3 Compound purification  
Semi-preparative HPLC was used for separation of the metabolites which were 
produced by A-2-28. Semi preparation of 1.2 grams crude extract obtained from 12 L 
cultures was carried out with Merck Hitachi Elite LaChrom system 2 with a gradient from 
20% B at 0 min increasing to 80% B at 15 min, to 100% B from 27 min to 27.5 min, flow 
14 ml/min. 
100 mg fraction 1 consisted of 3 compounds MW 129, MW 158, and MW 175 was 
eluted at 15 min. 180 mg fraction 2 was eluted at 5 to 7 min and 60 mg pure compound 2 
(MW 327/654) was obtained. 28 mg fraction 3 [compound 3 (MW 716), compound 2, and 
compound with MW 158] was eluted at 16.5 min, and 7 mg fraction 4 [compound 2 (MW 
327/654) and compound 4 (MW 334/668)] was eluted at 18 min. 
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   To purify fraction 1 (MW 129, 158, 175), preparation of 100 mg fraction 1 was 
carried out by using of Merck Hitachi Elite LaChrom system 2 m with a gradient from 5% 
B at 0 min increasing to 100% B at 25 min to 27 min, flow 14 ml/min. 1.5 mg of pure 
compound with MW 129 was eluted at 19 min, and 20 mg of the mixtures of this compound 
with compound MW 158 were eluted at 15 min. The compound with MW 175 was not 
found after second preparative HPLC separation.  
The same gradient, and column as for purification of compound 1 (MW 129) was 
applied to purify the compound 3 (MW 716) with Merck Hitachi Elite LaChrom system 2. 
The compound 3 was eluted at 17 min and 1 mg pure compound was obtained. The mass of 
this compound was changed during the preparation time along with the emergence of a new 
mass which was previously not available in the fraction. Consequently, the compound 3 
might be an unstable compound and was not further separated. The compound 4 was found 
in very low amounts in 7 mg of fraction 4, so that this compound was not purified.  
 
3.3.4 Metabolic profile 
Chemical analysis of metabolite profiles of the strain A-2-28 are shown in Table 3.7 
Table 3.7 Chemical profiles and purified compounds of the strain A-2-28. 
CNo 
Peak 
Media MW 
Rt 
[min] 
UV [nm] 
maxima 
CP/yield CN/comment 
1* 
GYM/100 
ml BM/100 
ml GYM/1 L 
129     
158     
175 
1.8 
229, 273, 
sh278, 289 
Purification; 
(MW 129)      
1.5 mg 
Maybe a 3-
indolylacetic 
acid (MW 175) 
2 
GYM/100 
ml BM/100 
ml GYM/1 L 
327/654 3.5 
225, 292 
sh360, 
sh375, 390 
Purification; 
60 mg 
Unknown        
Maybe new 
3 
GYM/100 
ml BM/100 
ml GYM/1 L 
716 3.7 
226, 326, 
405, 536 
Purification;   
1 mg 
Unknown        
Maybe new 
4 
GYM/100 
ml BM/100 
ml GYM/1 L 
334/668 3.9 224, 395 
No 
purification 
Unknown        
Maybe new 
* Peak 1 consists of 3 compounds (MW 129, MW 158 and MW 175), CNo: compound number; 
MW: molecular weight; Rt: retention time; CP: compound purification; CN: compound name. 
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Peak 1 included 3 compounds with MW 129, MW 158 and MW 175. This peak was 
found in 100 ml culture in GYM and BM at low amounts. Those three compounds 
possessed similar UV max 229, 273, 278 and 289.  Whist the compound 2 (MW 327, UV 
max 225, 292 sh 360, sh 375, 390) was found in large amount in both media. The 
compound 3 (MW 716, UV max 226, 326, 405, 536) was present in very low amounts in 
BM (100 ml cultures), and the compound 4 (MW 334, UV max 224, 395) was likely found 
with very low amounts in 100 ml cultures in GYM (Table 3.7, Figure 3.13). 
 
 
Figure 3.13 Chemical profiles of A-2-28 in 100 ml cultures. Red-mass, blue-UV.  
 
All compounds (compounds in peak 1, compound 2, 3 and 4) were produced in 100 
ml cultures and in 1 L cultures in GYM, in addition to compound 5 with unidentified mass. 
Although the compound 5 showed very good UV signals. It could not be isolated due to the 
very low amounts in the crude extract (Figure 3.14, Figure 3.15). Compounds 2 (MW 327) 
and 3 (MW 716) were produced in large amounts and had good UV signals, while 
compounds of peak 1 and the compound 4 (MW 334) were present in very low amounts, the 
latter compound showed rather weak UV signals as well (Figure 3.14, Figure 3.15). 
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Figure 3.14 Chemical profiles of A-2-28 in 1 L in GYM medium. Red-mass, blue-UV. 
 
 
Figure 3.15 UV spectrums of A-2-28 in GYM and BM (100 ml) and 1 L cultures in GYM. 
 
Searching data from DNPs by molecular weight, UV maxima and biological sources 
revealed that compounds of peak 1 (MW 129, 158, 175), compound 2 (MW 327), 
compound 3 (MW 716) isolated from Micrococcus sp. A-2-28 in this study were not 
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isolated from this genus so far. Moreover, the compounds with MW 129, 327 and 716 
which were produced by this strain showed good enough UV signals for isolation. 
Therefore, these compounds were purified.  
 
3.3.5 Bioactivities of the isolated compounds 
The biological activities of three purified compounds are shown in Table 3.8. The 
compounds 1 (MW 129) and 2 (MW 327) were inactive in all tests, whilst the compound 3 
(MW 716) showed weak inhibition of T. rubrum with 24.0% and inhibited the enzyme 
phosphodiesterase 4β2 (PDE4) with 43.0%. The other tests were not done due to lack of 
material. 
Table 3.8 Bioactivities assays of pure compounds isolated from A-2-28. 
 (The numbers indicate the percentage of inhibition, (-) indicate negative results) 
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1 (MW 129) - - - - - - - - - - - - - - - 
2 (MW 327) - - - - - - - - - - - - - - - 
3 (MW 716) - - * - * * - * 24 * - * - 43 - 
* The test was not performed due to limitation of purified compound.  
 
3.3.6 Discussion 
Among the compounds of peak 1, there was no hit for compounds with MW 129 
(UV max 229, 275) and MW 158 (UV max 230, 281). Whereas, the compound with MW 
175 (UV max 229, 273, sh 278, sh 289) might be a 3-indolylacetic acid (IAA) which was 
isolated from marine alga Undaria pinnatifida (Abe et al. 1972). This substance has UV 
maxima 229, 273, 278, 289 in MeOH which perfectly matched the compound with MW 175 
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in this study. This compound was isolated from the marine alga and is widely distributed in 
higher plants, bacteria, algae, yeasts and fungi (DNPs).  
The compound with MW 129 that might be considered as unknown compound was 
purified. The compounds with MW 158 and MW 175 were not purified due to limited 
amount in the crude extract. The structure elucidation of the compound with MW 129 is in 
progress. 
There was only one close hit for compound 2 (MW 327, UV max 225, 292, sh 360, 
sh 375, 390). It was proviolacein (MW 327, UV max 271, 290, 385, 412, 492) produced by 
Chromobacterium violaceum (Hoshino et al. 1995). However, proviolacein has been 
reported as a red pigment in MeOH (DNPs) while the purified compound 2 was not. In 
addition, the UV maxima of compound 2 did not match the UV spectra of proviolacein. 
Consequently, the compound 2 was an interesting compound. Structure elucidation is in 
progress. 
Similar, the compound 3 was an unknown compound. Rubiflavin D (MW 716, UV 
max 204, 230, 245, 280, 313, 408, 429) isolated from Streptomyces griseus (Nadig and 
Séquin, 1987) was found most similar to the compound 3 (MW 716, UV max 226, 326, 
405, 536). Moreover, rubiflavin D (DNPs) has been reported as orange substance whereas 
the purified compound 2 was a pink pigment. As a result, the compound 2 was regarded as 
unknown compound and attempted to be purified. However, 1 mg of compound 3 was 
purified and severed for several bioassays. The mass of this compound changed during the 
preparation along with the emergence of a new mass which was previously not seen in the 
fraction. Consequently, the compound 3 might be an unstable compound and was not 
further separated. So the structure elucidation of this compound was not performed due to 
limited amount of purified compound obtained. 
There were 2 hits for compound 4 (MW 334/668). The first hit was 6-
methyldihydrolindbladione (MW 334, UV max 269, 324, 389) isolated from myxomycete 
Lindbladia tubulina. This compound was red and was inactive against P388/S (murine 
leukemia sensitive P388 cell line) and P388/VCR (vincristine resistant P338 cell line cell) 
in the absence of VCR, but it was active against P388/VCR cell in the presence of VCR 
(Misono et al. 2003). The second hit was palmarumycin CP3 (MW 334, UV 290, 299, 307, 
313, 327, 381) isolated from the fungi Coniothyrium palmarum. Palmarumycin was 
colourless and showed equal activity against Gram-positive (B. megaterium) and Gram-
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negative bacteria (E. coli). It was particularly active against fungi Ustilago violacea, 
Mycotapha microspore, Fusarium oxysporum, Eurotium repens, and in addition against the 
alga Chlorella fusca (Krohm et al. 1994). 
In contrast to the crude extract of this strain, all three purified compounds (MW 129, 
MW 327, and MW 716) were inactive against S. epidermidis. It was inferred that the 
corresponding compound for inhibition of test organism was not isolated.  
The compound MW 175 (included in peak 1) was regarded as 3-indolylacetic acid or 
IAA (Figure 3.16). As my knowledge this phytohormone was not reported to be an 
antibacterial agent so far. The last two metabolites, the compounds with MW 158 (member 
of peak 1) and the compound 4 (MW 334) were produced in very low amounts in GYM and 
BM, and might cause the rather weak inhibition of the crude extract toward S. epidermidis. 
 
 
Figure 3.16 Structure of 3-indolylacetic acid (IAA). 
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3.4 Bacillus sp. C-1-10 
3.4.1 Origin, cultivation and identification of the strain C-1-10 
The strain C-1-10 was originally isolated from A. digitatum in the Baltic Sea in TM 
medium and was identified as Bacillus sp., based on 16S rRNA sequence analysis. Strain C-
1-10 showed 99.8% sequence similarity with Bacillus amyloliquefaciens NBRC 15535
 T
 
(GenBank accession number AB255669), and shared 99.7% sequence similarity with 
Bacillus methylotrophicus CBMB 205
T
 (GenBank accession number EU194897) and 99.5% 
sequence similarity with Bacillus vallismortis DSM11031
T 
(GenBank accession number 
AB021198) respectively. 
 
3.4.2 Cultivation and extraction of the strain C-1-10 
Chemical analyses of metabolites after growth in GYM and BM (100 ml cultures) 
showed that the strain C-1-10 produced 7 compounds in both media. Beside those present in 
BM medium, additional metabolites were produced in GYM. There were 8 interesting 
compounds found in 100 ml cultures in GYM medium with rather large amounts and also 
good UV signals. Therefore, the strain C-1-10 was scaled up to 1 L in GYM medium. Broth 
of 10 L cultures in total was extracted with ethyl acetate and applied to preparation.  
 
3.4.3 Compound purification 
Semi-preparative HPLC was used for separation of the metabolites which were 
produced by C-1-10. Preparation of 2.2 grams crude extract obtained from 10 L cultures 
was carried out with Merck Hitachi Elite LaChrom system 2 with a gradient from 10% B at 
0 min increasing to 100% B from 25 min to 27 min (flow 14 ml/min), and yielded 430 mg 
fraction 1 at 9 to 16 min, 50 mg fraction 2  at 16 to 18 min, 40 mg fraction 3 at 18 to 22 
min, 60 mg fraction 4 at 23 min, 160 mg fraction 5 at 24 min, and 120 mg fraction 6 at 24.5 
min. 
Compound 1 (MW 686) was found in fraction 1 in very low amounts. This fraction 
was purified with the same gradient and HPLC system as for the preparation of crude 
extracts. The fraction 1 was separated into two peaks with different retention time (2.9 min 
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and 3.3 min), but with identical UV maxima and molecular weigh 686. This compound 
needs to be further purified. 
Two isomer compounds (the compound 13 and 14 with MW 462) which also were 
unknown compounds were found in fractions 2 and 3. In contrast to the UV signals in crude 
extract (with standard HPLC), the UV signals of those compound were found very weak in 
Merck Hitachi Elite LaChrom system 2, when they were applied for preparation. In addition 
those isomers existed in both fractions with very low amounts. Therefore those isomers 
were not considered to further preparation.  
To purify compounds 4 (MW 993) and 5 (MW 1007), preparation of 60 mg fraction 
4 was carried out by using Merck Hitachi Elite LaChrom system 2 with a gradient from 
70% B at 0 min increasing to 100% B at 13 min to 14.5 min, (flow 14 ml/min). The pure 
compound 4 was yielded 3.5 mg and the pure compound 5 was yielded 6.5 mg. 
To purify compounds 6 and 7, 160 mg of fraction 5 were applied to preparation with 
Merck Hitachi Elite LaChrom system 2 using the same gradient as for the purification of 
fraction 4. The pure compound 6 (MW 1021) was yielded 60 mg and the pure compound 7 
(MW 1035) was yielded 4 mg. 
Four compounds (4 to 7) which were considered as known cyclic peptides were 
isolated from the strain C-1-10. The other fractions 1, 2, and 3 including compound 1 (MW 
686), compound 18 (MW 366), the known cyclic peptides (MW 1030 and MW 1044), 
isomer compound (MW 462), and fraction 6 (mix of 3 known cyclic peptides MW 1007, 
MW 1021, MW 1035) will be further analysed.  
 
3.4.4 Metabolic profile 
The substances identified in strain C-1-10 in 100 ml cultures in GYM and BM media 
are shown in Table 3.9 and Figure 3.17. This strain produced at least 7 compounds 
(compound 1-7) in both media. One out of those compounds was unknown (compound 1, 
MW 686). The other compounds might be all known. The compound 2 (MW 772, UV max 
231, 275, 328) might be an O-demethylpaulomycin A (MW 772, UV max 236, 274, 321) 
which was isolated from Streptomyces paulus (Argoudelis et al. 1988). Compound 3-7 
might be known cyclic peptides. The compound 3 (MW 502, UV max 233) might be a 
cyclic hexapeptide bistratamide C (MW 502, UV max 233) which was isolated previously 
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from the ascidian Lissoclinum bistratum (Foster et al. 1992). The known cyclic peptides 
[compound 4 (MW 993), compound 5 (MW 1007), compound 6 (MW 1021) and compound 
7 (MW 1035)] were major compounds produced by the strain C-1-10. Those main produced 
cyclic peptides were successful isolated. The structure elucidation now is in progress. 
Table 3.9 Chemical profiles and purified compounds of the strain C-1-10. 
CNo 
Peak 
Media MW 
Rt 
[min] 
UV [nm] 
maxima 
CP/yield CN/comment 
1 
GYM/100 ml 
BM/100 ml 
GYM/1L 
686 3.7 233, 271, 323  
Not    
successfully 
purified 
Unknown 
Maybe new 
2 
GYM/100 ml 
BM/100 ml 
GYM/1L 
772 5.2 231,275, 328 
No 
purification 
Maybe an 0-
demethylpaulo
macin A 
3 
GYM/100 ml 
BM/100 ml 
GYM/1L 
502 6.0 230 
No 
purification 
Maybe  a         
bistratamide C 
4 
GYM/100 ml 
BM/100 ml 
GYM/1L 
993 6.2 226, 279 
Purification; 
3.5 mg 
 
Maybe a 
surfactin 
5 
GYM/100 ml 
BM/100 ml 
GYM/1L 
1007 6.3 226, 280 
Purification; 
6.5 mg 
 
Maybe a 
surfactin 
6 
GYM/100 ml 
BM/100 ml 
GYM/1L 
1021 6.4 225, 278 
Purification; 
60 mg 
 
Maybe a 
bacillopeptin A 
7 
GYM/100 ml 
BM/100 ml 
GYM/1L 
1035 6.5 226, 278 
Purification; 
4 mg 
 
Maybe a 
bacillopeptin B 
8 
GYM/100 ml 
 
758 3.4 
227, 284, 305 
320, 337, 355  
No 
purification 
Unknown  
9 
GYM/100 ml 
 
742 3.8 
232, 270, 306 
322, 338, 357 
387 
No 
purification 
Unknown 
 
10
* GYM/100 ml 
 
742 
744 
4.0 
226, 286, 324 
341, 362, 384 
No 
purification 
Unknown    
11 
GYM/100 ml 
 
726 4.1 
235, 273, 322 
343, 350, 362 
384 
No 
purification 
Unknown 
12 
GYM/100 ml 
 
580 4.5 
223, 285, 327 
345, 349, 363 
383 
No 
purification 
Unknown    
13* 
GYM/100 ml 
GYM/1L 
745 
462 
4.8 236, 274, 286 
No 
purification 
Unknown  
14 
GYM/100 ml 
GYM/1L 
462 5.1 235, 273, 286 
Not    
successfully 
purified 
Unknown    
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CNo 
Peak 
Media MW 
Rt 
[min] 
UV [nm] 
maxima 
CP/yield CN/comment 
15 GYM/100 ml 446 5.8 233, 272, 286 
No 
purification 
Unknown    
16 BM/100 ml 586 3.6 
235, 270, 309 
324 
No 
purification 
Unknown    
17 
BM/100 ml 
GYM/1L 
1030 3.9 227, 276 
No 
purification 
Maybe a 
bacillomycin 
D1 
18 
BM/100 ml 
GYM/1L 
366 4.1 235, 268, 311 
No 
purification 
Maybe a 
paecilomycin 
E/F 
19 
BM/100 ml 
GYM/1L 
1044 4.2 227, 275 
No 
purification 
Maybe a 
bacillomycin 
D2 
20 
BM/100 ml 
GYM/1L 
1058 4.3 
Could not be    
determined 
No 
purification 
Maybe a 
bacillomycin 
D4/5 
21 BM/100 ml 766 4.7 231, 275, 287 
No 
purification 
Unknown    
22 
BM/100 ml 
GYM/1L 
780 4.9 235, 273, 287 
No 
purification 
Unknown  
23 BM/100 ml 787 5.1 233, 274, 287 
No 
purification 
Unknown    
24 BM/100 ml 779 5.2 
Could not be    
determined 
No 
purification 
Unknown  
* Each of peaks 10 and 12 consist of 2 compounds MW 742, MW 744 and MW 745, MW 462, 
respectively. CNo: compound number; MW: molecular weight; Rt: retention time; CP: compound 
purification; CN: compound name. 
 
Searching of molecular weight and biological sources revealed that Bacillus spp. 
were sources of lipopeptides including members of surfactin class and iturin class. 
Compounds with molecular weight 993, 1007, 1021 and 1035 were surfactins produced by 
B. subtilis OKB 105 (Kowall et al. 1998). But no UV information was available for these 
surfactins. The compounds 4 (MW 993, UV max 226, 279) and 5 (MW 1007, UV max 226, 
280) which were produced by Bacillus C-1-10 in this study might be surfactin relative 
substances. Compound 6 (MW 1021, UV max 225, 278) and compound 7 (MW 1035, UV 
max 226, 278) might be bacillopeptin A (MW 1021, UV max 228, 278) and B (MW 1035, 
UV max 228, 278), respectively (Kajimura et al. 1995). 
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In addition to these compounds produced in both media (black numbers), this strain 
produced compounds 8-15 (blue numbers) in 100 ml cultures in GMY medium and 
compounds 16-24 (green numbers) in 100 ml cultures in BM medium (Figure 3.17). 
 
 
Figure 3.17 Chemical profiles of C-1-10 in 100 ml cultures. Red- mass, blue-UV. 
 
 
These 8 different compounds which were produced in 100 ml cultures in GYM 
medium were unknown compounds, while at least 3 out of 9 compounds produced in 100 
ml cultures in BM were known cyclic peptides (compounds 17, 19 and 20). In addition of 
the 5 known cyclic peptides mentioned above, this strain might be produce bacillomycin D 
derivatives, the compound 17 (MW 1030), the compound 19 (MW 1044) and the compound 
20 (MW 1058) might be considered as bacillomycin D1, bacillomycin D2, and bacillomycin 
D4/5, respectively, all known as products of B. subtilis (Peypoux et al. 1984). 
The mass analysis is shown in Figure 3.17. At 4.0 min in GYM 100 ml was m/z 725 
and m/z 727 in positive mode. It were found m/z 725 [M+H-H20]
+
, m/z 743 [M+H]
+
, and 
m/z 765 [M+H+Na]
+ 
together with m/z 727 [M+H-H20]
+
, m/z 745 [M+H]
+
, and m/z 767 
[M+H+Na]
+
. Therefore, the true molecular weights for these compounds were 742 and 744. 
Because the compounds MW 742 and MW 744 existed in the same retention time and had 
similar UV maxima so that these compounds were listed in peak 10. Also, the mass of the 
compound 12 which was given by automatic analysis in Figure 3.17 at 4.5 min was 563. 
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The true molecular weight of this compound was decided as 580 because of the m/z 563 
[M+H-H20]
+
, m/z 581 [M+H]
+
, and 603 [M+H+Na]
+
 . 
Beside the major cyclic peptide products, the compound 10 (MW 742, MW 744), the 
compound 11 (MW 726), the compound 12 (MW 580), and two interesting isomer 
compounds (13, 14) with molecular weight 462 were presented in rather high amounts and 
showed good UV signals (Rt at 4.0 to 5.1 min) in GYM 100 ml cultures (Table 3.9, Figure 
3.17, Figure 3.19). At the similar retention time of compounds 10 to 12, known cyclic 
peptides were found. These were compound 19 (MW 1044) and 20 (MW 1058) either 
present at rather low amounts and with weak or no UV signals (Table 3.9, Figure 3.17). At 
similar retention time and UV maxima, compounds 21 (MW 767), 22 (MW 780), and 23 
(MW 787) were found as major compounds in screening BM, while two isomers 
(compound 13 and 14) were found in 100 ml cultures in GYM medium (Table 3.9, Figure 
3.17, Figure 3.19). 
Other compounds were produced in 100 ml cultures in both media either at low 
amounts or revealed weak UV signals. These were the compounds 8, 9, and 15 in GYM, 
and the compounds 16, 17, and 24 in BM. 
The metabolites of the strain C-1-10 in 1 L cultures in GYM medium are shown in 
Table 3.9, Figure 3.18, and Figure 3.19 
This strain produced 7 compounds [compound 1 (MW 686), compound 2 (MW 
772), and 5 cyclic peptides (compounds 3-7)]. In addition, compound 13, 14 which were 
produced in GYM 100 ml cultures and compound 17, 18, 19, 20 and 22 which were found 
in BM 100 ml cultures were available in 1 L cultures in GYM medium. The known cyclic 
peptides (compound 4-7) which were originally isolated from Bacillus species were major 
products with high amounts in mass and rather good UV signals, whilst compound 3 which 
is considered as hexapeptide from the ascidian Lissoclinum bistratum and others existed in 
very low amounts. The known cyclic peptides which were produced in 100 ml cultures in 
BM medium were also found in big scale cultivation in 1 L in GYM medium. These were 
compounds 17 (MW 1030), 19 (MW 1044), and 20 (MW 1058) with rather low amounts 
and weak UV signals. The isomer compounds (compounds 13 and 14 with MW 462) were 
found in rather low amounts in GYM 1 L cultures. The compound 14 with MW 745 (100 ml 
cultures in GYM) and compound 22 with MW 780 (100 ml cultures in BM) were also found 
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in GYM 1 L cultures. They shared the same UV maxima and retention time to one out of 
two isomers (MW 462). 
 
 
Figure 3.18 Chemical profiles of C-1-10 in 1 L cultures GYM medium. (Red-mass, green-presented 
of mass 687 in two different times, blue-UV). 
 
 
Figure 3.19 UV spectrums of C-1-10 in GYM and BM (100 ml) and 1 L cultures in GYM. 
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3.4.5 Bioactivities of the isolated compounds 
The biological activities of four purified compounds are described in Table 3.10.  
Table 3.10 Bioactive activities of pure compounds isolated from C-1-10. 
 Compounds Antibacterial Antifungal Cytotoxic 
Enzyme 
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4 (MW 993) - 52 86 - - - - - - - - - - 39 - 
5 (MW 1007) 23 96 98 22 - - - - - - - - - - - 
6 (MW 1021) - 75 74 - - - - - - - - - - 31 - 
7 (MW 1035) 23 53 63 - - - - - - - - - - 41 - 
The numbers indicate the percentage of inhibition, (-) indicate negative results. 
 
All four compounds showed inhibition of S. epidermidis and also MRSA. The 
compound 5 with molecular weight 1007 showed rather weak inhibition of Gram-negative 
E. coli and was inactive to phosphodiesterase 4, while the other compounds were inactive to 
E. coli and active against phosphodiesterase 4. However, all four pure compounds were 
inactive to other Gram-negative bacteria and fungi and exhibited no cytotoxic activity, and 
no inhibition to glycogen synthase kinase, and protein-tyrosine-phosphatase.  
 
3.4.6 Discussion  
There were several hits from databases for the compound 1 (MW 686, UV max 233, 
271, 323). However, all hits did not perfectly match both the biological sources and the UV 
maxima. For instance, the compound excelside B (MW 686, UV max 230, 275, 283) was 
isolated from the seeds of Fraxinus excelsior and reported as inhibition of adipocyte 
differentiation in 3T3-lL1 cell (Bai et al. 2010). The compound mayoside C (MW 686, UV 
max 226, 276, 350) was a constituent of the bark of Picramnia teapensis (Rodr  guez-
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Gamboa et al. 2000). There was no hit from microbial sources for compound 1. Therefore, 
this compound might be interesting for chemical structure analysis. As mentioned above, 
the fraction 1 was purified in order to isolate the pure compound 1.  
Before preparation of the fraction 1, the UV spectra of metabolites in 1 L cultures in 
GYM medium showed that there were some compounds with strong UV signals at 2.5 to 
3.5 min (Figure 3.18-blue line, Figure 3.19-GYM 1 L). However, the mass of all 
compounds which were eluted at this retention time could not be identified, due to 
limitation of amounts of the compounds (Figure 3.18). The compound 1 (MW 686) which 
was regarded as interesting compound was detected at this retention time. This was 
confirmed by analysis of extracted ion chromatogram (EIC) of mass 687 (green line in 
Figure 3.18). The mass 687 (MW 686) was found at 2.9 min and 3.3 min with similar UV 
maxima (Figure 3.18, Figure 3.19, Figure 3.20). Due to presentation in crude extract with 
very low amounts, the compound with MW 365/765 was only found in the fraction 1 after 
preparation of crude extract, this compound was notably remarked because its existence 
next to the compound 1 in addition with good UV signals (green line in Figure 3.18). Due to 
limitation amount of crude extract, the compound 1 was conserved for further separation. 
After semi-preparation, with the range of retention time 2.5 to 3.5, the compound 1 
(MW 686) was found as isomers with UV maxima 230, 273 (MeOH). The mass 365/765 
was found in rather low amounts but very good UV signals (UV maxima 237, 268, 323) at 
3.2 min (Figure 3.20).  
 
 
 
Figure 3.20 UV spectrums of metabolites of the strain C-1-10 after preparation. 
 
 
The compound with MW 364 and UV max 234, 272, 312 might be an antibiotic LL 
Z1640-1 (MW 364, UV max 234, 272, 312) isolated from unidentified fungus and 
possessed antiprotozoal activity (Ellestad et al. 1978). Other hit was a zeaenol or antibiotic 
LL-Z1640-4 (MW 364, UV max 234, 271, 314) isolated from Drechslera portulacae 
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(Sugawara et al. 1992). Antibiotic LL Z1640-1 and zeaenol isolated from Gorgonian 
derived fungus Cochliobolus lunatus showed antifouling properties (Shao et al. 2011).  
The molecular weight and UV maxima of compound 2 (MW 772, UV max 231, 275, 
328) matched to those of 0-demethylpaulomycin A (MW 772, UV max 236, 274, 321) 
which was isolated from S. paulus. This compound (Figure 3.21) was reported to be active 
against Gram-positive bacteria, especially S. aureus (Argoudelis et al. 1988a). 
 
 
Figure 3.21 Structure of 0-demethylpaulomycin A. 
 
The compound 3 (MW 502, UV max 230) might be the cyclic hexapeptide 
bistratamide C (MW 502, UV max 234 in CH2Cl2), which was isolated from the ascidian 
Lissoclinum bistratum (Foster et al. 1992). The other hit was aleurodiscal (MW 502, UV 
max 237) isolated from Aleurodiscus mirabilis. This compound was reported as antifungal 
agent inhibition of Fusarium oxysporum, Mucor miehei, Absidia glauca, Alternaria porri, 
Ascochyta pisi, Aspergillus ochraceus, Verticillium sp. 153-83, and Zygorrhynchus moelleri 
with 2 µg /disc by agar diffusion assay method. But no antibacterial activity was observed 
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with B. subtilis, E. coli, and S. aureus with minimum inhibitory concentration (MIC) ˃100 
µg/ml (Lauer et al. 1989). 
As mentioned above for known surfactins which had similar molecular weight to 
compounds 4 (MW 993) and 5 (MW 1007) there was no UV information (see 3.4.4) 
Searching of MW and UV maxima revealed that micropeptin EI 992 (MW 993, UV 
max 224, 280) and hymenamide K (MW 1007, UV 221, 280) were similar to compounds 4 
(MW 993, UV 226, 279) and 5 (MW 1007, UV max 226, 280) from this present study. 
Micropeptin EI 992 isolated from cyanobacterium was described as colourless oil, trypsin 
inhibitor (Ploutno et al. 2002). Hymenamide K isolated from a marine sponge 
Hymeniacidon sp. was a proline containing cyclic octapeptide and showed inhibition of 
protein tyrosine kinase at concentration 73 µg/ml (Tsuda et al. 1994). However, the 
compound 4 isolated from C-1-10 was white solid substance and showed antibacterial 
activity against Gram-positive bacteria and inhibited phosphodiesterase 4, whereas 
compound 5 inhibited Gram-positive bacteria and also Gram-negative bacteria and showed 
no inhibition of any tested enzymes. 
As mentioned above, compounds 6 (MW 1021) and 7 (MW 1035) were regarded as 
bacillopeptin A and B. However, these compounds isolated in this present study were 
antimicrobial substances. They showed antimicrobial activity against Gram-positive 
bacteria (Table 3.10), while bacillopeptin A and B isolated from B. subtilis FR-2 did not 
show any activity against bacterial and fungal tests including B. subtilis. E. coli, and C. 
albicans (Kajimura et al. 1995).  
The compound 8 with MW 1049 was produced by Bacillus sp. strain H-6 (see 3.2.4). 
It might be a bacillopeptin C (MW 1049, UV max 229, 278), an antifugal cyclic peptide 
against C. albicans (Kajimura et al. 1995). However, this compound was not found in the 
crude extract of the strain C-1-10 in 100 ml cultures and also in 1 L cultures.  
The crude extract of the strain C-1-10 showed inhibition of four test 
microorganisms. Four purified compounds showed no inhitibion of C. albicans. Thus, the 
compound which responded to C. albicans inhibition was not identified.  
The genus Bacillus sp. is a well-known source of cyclic peptides so far. They had 
similar molecular weight to some compounds isolated in this study. However, UV 
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information was not available. For examples, surfactins 1 (MW 1035), and 2 (MW 1021) 
produced by B. subtilis natto showed moderate anti HIV activity (Itokawa et al. 1994). 
Bacillomycin L (MW 1021, normal-C14) isolated from B. subtilis showed weak antifungal 
activity against Ophiostoma ulmi and Cryphonectria parasitica, while bacillomycin L1,2 
(MW 1035, anteiso C15 and iso C15) and bacillomycin L3,4 (MW 1049, iso C16 and n-C16) 
showed stronger activity than those of bacillomycin L (Eshita et al. 1995). Halobacillin 
(Figure 3.22), which was produced by a marine Bacillus sp. was an acylpeptide of the iturin 
class with MW 1035. Halobacillin showed moderate human cancer cell cytotoxicity, no 
antifungal, and no antibiotic activities (Trischman et al. 1994). 
 
 
Figure 3.22 Structure of halobacillin (Trischman et al. 1994). 
 
The compounds 4 (MW 993), 5 (MW 1007), 6 (MW 1021), and 7 (MW 1035) were 
the major compounds produced by strain C-1-10. They were successfully purified by UV-
HPLC separation and showed different antimicrobial activities to known cyclic peptides 
from DNPs. This study suggested that compound 4 (MW 993), 5 (MW 1007), 6 (MW 1021) 
and 7 (MW 1035) might be relative cyclic peptides. Further detailed NMR analysis is 
required to confirm the name and structure of each compound.  
The search by molecular weight and UV maxima yielded 5 hits for compound 8 
(MW 758 UV max 227, 284, 305, 320, 337, 355). Three hits were original sources from 
microorganisms. These were 0-demethylpaulomycin B (MW 758, UV max 237, 276, 320) 
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isolated from S. paulus (Argoudelis et al. 1988a), antibiotic disorazole A1 (MW 758, UV 
max 251, 265sh, 272, 298, 306, 321sh) which was produced by a myxobacterium 
Sorangium cellulosum strain So ce 12 (Jansen et al. 1994), and unguisin A (MW 758, UV 
max 219, 274, 281, 290) isolated from marine fungus Emericella unguis (Malmstrom, 
1999). Disorazole A1 showed strong inhibition of many fungi but no inhibition of yeasts 
(Sacharomyces cerevisiae, C. albicans, Debaryomyces hansenii) and bacteria including of 
B. subtilis, S. aureus, Micrococcus luteus, Streptococcus faecalis, E. coli and Salmonella 
typhimurium (Irschik et al. 1995; Hopkins and Wipf, 2009). Unguisin A showed moderate 
inhibition of S. aureus and Vibrio parahaemolyticus (Malmstrom, 1999). Other hits had the 
same molecular weight but different in UV maxima and biological sources.  
The best hit for compound 9 (MW 742, UV max 232, 270, 306, 322, 338, 357, 387) 
were bacillaene B (MW 742, UV maxima 292, 328, 343, 361, 382) which was isolated from 
B. amyloliquefaciens strain FZB 42 (Moldenhauer et al. 2010) and licoagrone (MW 742, 
UV max 230, 278, 324, 396) isolated from hairy root cultures of plant Glycyrrhiza glabra 
(Asada et al. 1999). 
The most similar hit to compound 10 (MW 744, UV max 226, 286, 324, 341, 362, 
384) was paulomycin D (MW 744, UV max 236, 275, 321) which was isolated from S. 
paulus. This compound showed activity against the Gram-positive bacteria S. aureus, S. 
epidermidis, S. faecalis and S. pneumoniae (Argoudelis et al. 1988b). 
Searching by molecular weight and UV maxima revealed that unguisin B (MW 726, 
UV max 220, 274, 280, 290) which was isolated from the marine fungus Emericella unguis 
(Malmstrom, 1999) and bambusicolaside IV (MW 726, UV max 232, 298, 344, 356, 456) 
were most similar to compound 11 with MW 726 and UV maxima 235, 273, 322, 343, 350, 
362, 384 (Zhang et al. 1997). 
The best hit for compound 12 (MW 580, UV max 223, 285, 327, 345, 349, 363, 383) 
was bacillaene with molecular weight 580 and UV maxima 292, 328, 343, 361, 382. 
Bacillaene was isolated from B. subtilis, and is active against a broad spectrum of bacteria 
inhibiting prokaryotic protein synthesis and showed strong inhibition of E. coli (Patel et al. 
1995). 
The compounds 13 and 14 with identical MW 462 and UV maxima 235, 272, 286 
but different retention time (4. 8 and 5. 1 min) were found in GYM medium (100 ml and 1 
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L cultures). The two compounds might be considered as isomer compounds. No hits were 
found for these compounds from DNPs by searching of MW and UV maxima and 
biological sources as well. The most similar compound was aranotin (MW 462, UV max 
222, 270) which was isolated from Arachniotus aureus, and showed antiviral property 
(Nagarajan et al. 1968). Other possible hits to this compound with molecular weight 462 
were mostly isolated from plants. For example, bletilol C (MW 462 UV max 234, 274, 285, 
302) was found in the tubers of Bletilla striata (Yamaki et al. 1993) and phyllodulcon 8-
glucoside MW 462, UV max 233, 285, 295 was isolated from leaves of the plant Hydrangea 
macrophylla var. thunbergii and supported for the polyphenol biosynthesis in host plant 
(Suzuki et al. 1977).  
Chemical analysis of metabolite of crude extract in 1 L cultures showed that peak 13 
including of two compounds with MW 462 and MW 745, compound 14 (MW 462), and 
compound 22 (MW 780) were found at 4.8 to 5.1 min with similar UV maxima (Table 3.9). 
Mass spectrum showed that the isomers (MW 462) existed in rather low amounts, and the 
compound 22 and compound with MW 745 were found in a bit higher amounts. These 
compounds existed in this retention time showed good UV signals when the crude extract 
was applied in standard HPLC (Figure 3.18, Figure 3.19). As mentioned above, the isomers 
were regarded as interesting compounds and purified with semi preparation. The UV 
spectrum of fractions 2 and 3 after preparation showed that the main compound in those 
fractions were compound with MW 745 and compound 22, respectively. The isomers MW 
462 which were found in crude extract also presented after preparation of those fractions but 
in very low amounts, and shared UV maxima with compound MW 745. The compound 22 
was found in rather high amounts but in very weak UV signals. As a result, all compounds 
which were found in fractions 2 and 3 were not purified, because of either their existed in 
very low amounts or revealed in very weak UV signals.   
There was no clear hit for compound 15 (MW 446, UV max 233, 272, 286). The 
most similar compound was pseudopterosin E (MW 446, UV max 226, 275, 285) isolated 
from Pseudopterogorgia elisabethae. This diterpene glycoside showed very low acute 
toxicity in mice LC50 ˃300 mg/kg and was an anti-inflammatory agent (Roussis et al. 
1990). Other pseudopterosins possessed identical molecular weight 446 and UV maxima 
213, 232, 276, 285 for pseudopterosin P, UV maxima 228, 277, 284 for pseudopterosin T, 
and UV maxima 277, 284 for pseudopterosin K. Two other hits were derivatives of eruberin 
A, and pneumatopterin C. A derivate eruberin was abacopterin which was constituent 
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compound of Abacopteris penangiana with MW 446 and UV maxima 232, 276 (Zhao et al. 
2007). Pneumatopterin C was isolated from Pneumatopteris pennigera with MW 446 and 
UV maxima 230, 280 (Tanaka et al. 1997). 
The compound 16 (MW 586, UV max 235, 270, 309) was found in screening BM 
medium in very low amounts but very good UV signals. Searching by molecular weight, 
UV maxima and biological sources revealed that this compound is not known as product of 
Bacillus so far. Among some substances with similar molecular weight but different UV 
maxima compared to compound 16, the most similar compound was integracin B/C (MW 
585, UV max 225, 265, 302) isolated from Cytonaema sp. (Singh et al. 2002).   
The compound 18 (MW 366, UV max 235, 268, 311) might be a paecilomycin E 
(MW 366, UV max 233, 271, 311) or paecilomycin F (MW 366, UV max 253, 271, 314). 
Both were isolated from Paecilomyces sp. SC 0924 and a marine-derivate Cochliobolus 
lunatus (Xu et al. 2010).  
Compounds 17, 19 and 20 were considered as bacillomycin D1, bacillomycin D2, 
and bacillomycin D4/5, respectively (Peypoux et al. 1984). Recently, the compounds a1, a2 
and a3 which were bacillomycin D-like lipopeptides of 14, 15 and 16 carbon fatty acid long 
chains showed strong inhibition of C. albicans. Especially, compound a3 with molecular 
weight 1058 and very similar bacillomycin D structure had strongest antifungal activity 
(Tabbene et al. 2011). The compounds 17, 19, and 20 were considered as known peptides. 
All were found in 100 ml cultures in BM medium, and in 1 L cultures in GYM medium but 
with low amounts and weak UV signals. As a result, those compounds were not able to 
purify.  
The compound 21 (MW 766, UV max 231, 275, 287) had similar molecular weight 
with the antibiotic SB 22484 (MW 766), but different UV maxima (SB 22484, UV 232, 
327). This antibiotic SB 22484 was isolated from Streptomyces sp. (Selva et al. 1990).  
The most similar hit to compound 22 (MW 780, UV max 235, 273, 287) was 
kirrothricin isolated from Streptomyces cinnamonensis (Thein-Schranner et al. 1982). 
The most similar hit to compound 23 (MW 787, UV max 232, 274, 287) was the 
antibiotic BE 32030 also called BE 32030B (MW 787, UV max 242, 248, sh 258, 305). 
This substance was isolated from Nocardia sp. A 32030 and showed inhibition the growth 
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of P388 murine leukemia, DLD-1 human colon cancer, PC-13 human lung cancer and 
MKN-45 human stomach cancer cell lines (Tsukamoto et al. 1997).  
The compound 24 (MW 779) was found only in 100 ml cultures in BM medium and 
its UV maxima could not be determine, therefore this compound was not considered for 
further analysis.  
Analysis data from the literature revealed that compound 2 with MW 772 possessed 
the UV maxima matched to the UV maxima of the compound 0-demethylpaulomycin with 
MW 772 which was isolated from S. paulus. In addition, S. paulus also produced 
paulomycin D (MW 744), paulomycin D was found as closed hit for the compound 10 from 
this study.  
Unguisin A (MW 758) and unguisin B (MW 726) which were both isolated from 
marine derived fungus Emericella unguis, those compound were the closed hits for the 
compound 8 (MW 758) and the compound 11 (MW 726) in this study. Unguisins were 
cyclic heptapeptides contained gamma aminobutyric acid (GABA) in the ring, the synthetic 
cyclic peptide containing GABA has been tested as antitumor agent (Malmstrom, 1999).  
Bacillaene B (MW 742) and bacillaene A (MW 580) isolated from Bacillus genus 
were closed hits for the compound 9 (MW 742) and the compound 12 (MW 580) 
respectively. 
All close hits for compounds which were produced by the strain C-1-10 were 
bioactive substances. It was interesting to find that best hits for compounds 2 and 10, 
compounds 8 and 11, and compounds 9 and 12 were antibiotic substances which were 
produced by the same sources (S. Paulus: producer of hit compounds for compounds 2 and 
10, Emericella unguis: producer of hit compounds for compounds 8 and 11, Bacillus sp.: 
producer of hit compounds for compounds 9 and 12).  
Actual, further exploitation should be carried out analysis of the metabolites of the 
strain C-1-10 for identification of all its metabolites and for determination of biological 
activities as well.  
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DISCUSSION 
 
1. Phylogenetic classification of coral associated bacteria 
The aim of this study was the isolation, phylogenetic identification of bacteria 
associated with the soft coral A. digitatum living in the Baltic Sea, and the assessment of 
their production of antimicrobial compounds. Colonies derived from the soft coral samples 
were picked randomly from different media with the purpose to obtain a maximum of 
distinct characteristic colonies.  
From our results it is evident that Firmicutes, Gamma-, Alphaproteobacteria, and 
Actinobacteria contribute to the bacterial diversity of the soft coral A. digitatum. 
This relates to results from the literature in which another Alcyonium species was 
studied. Bacteria associated with the soft coral A. antarcticum yielded a high diversity of 
bacteria including Gamma-, Alpha-, Betaproteobacteria, Bacteroidetes, Firmicutes, 
Actinomycetales, Planctomycetes, sulphate-reducing bacteria, and Chlorobi by analysis of 
16S rRNA gene sequences, while results from culture dependent analysis revealed 
Gammaproteobacteria as major group. Psychrophilic bacteria were dominant whereas three 
out of ten cultures were identified as non-psychrophilic and non-marine bacteria (Webster 
and Bourne, 2007). Members of Bacillus were reported as most abundant bacteria isolated 
from algae, ascidians, and sponges from the North Coast of Sao Paulo state Brazil (Menezes 
et al. 2010). The Bacillus genus was also considered to be most abundant among the isolates 
from the black coral Antipathes dichotoma from South China Sea (Zhang et al. 2012) and 
from four sympatric gorgonian corals (Dichotella gemmacea, Melitodes squamata, 
Muricella flexuosa, and Subergorgia suberos) from the South China Sea (Peng et al. 2013). 
Other studies on the coral F. scutaria from the Red Sea did not report any member of the 
genus Bacillus (Lampert et al. 2006). 
The genus Lysinibacillus was the second dominant group of Firmicutes found in A. 
digitatum. To our knowledge, there was no report on Lysinibacillus associated with corals 
so far. It should be noted that representatives of the genus Paenibacillus were isolated 
mainly from terrestrial. Recently Paenibacillus profundus sp. was reported as a new species 
from deep sea sediment (Romanenko et al. 2013). 
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There were very few reports of Paenibacillus members from invertebrates. The 
genus Paenibacillus was isolated from the black coral A. dichotoma from the South China 
Sea (Zhang et al. 2012) and the coral Mussismilia hispida from eastern Brazil (de Castro et 
al. 2010). Exiguobacterium sp. had been targeted as a mutualised relationship with coral 
host in Elkhorn coral Acropora palmate from Florida Key (Ritchie, 2006). In this study we 
reported on the isolation of Paenibacillus sp. and Exiguobacterium sp. from the soft coral A. 
digitatum. 
Several culture-dependent studies showed the presence of actinobacteria associated 
with the stony coral F. scutaria from the Red Sea (Lampert et al. 2006), the reef building 
coral A. digitifera from the Gulf of Mannar (Nithyanand and Pandian, 2009), the reef coral 
M. hispida from eastern Brazil (de Castro et al. 2010). Actinobacteria were also reported on 
the associated with  the cold water coral L. pertusa from the northeastern Gulf of Mexico 
(Galkiewicz et al. 2011), the black coral A. dichotoma from the South China Sea (Zhang et 
al. 2012), and the deep sea Gorgonian coral from the South China Sea (Gray et al. 2011). A 
few cultivation independent studies have reported that a large number of the Actinobacteria 
were associated with the reef building coral Pocillopora damicornis from the Great Barrier 
Reef (Bourne and Munn, 2005), the hard coral F. scutaria from  Red Sea (Lampert et al. 
2008), the cold water coral L. pertusa from the Trondheimsfjord (Norway) (Neulinger et al. 
2008), the reef building coral Acropora palmate, and with Porites astreoides from the 
Mexican Caribbean (McKew et al. 2012). By cultivation independent methods 
Actinobacteria and Alphaproteobacteria recovered from deep sea bamboo corals (in 
Warwick) from Gulf of Alaska seamounts were classified only as belonging to 
Actinomycetales order, Rhizobiaceae family and Rhodobiaceae at the family level but not at 
species levels (Penn et al. 2006). Therefore, it is not possible to correlate these data with the 
present study at the species level.  Actinobacteria were isolated from the closely related soft 
coral A. antarcticum (Webster and Bourne, 2007). However, those Actinobacteria isolated 
from previous studies were different to the isolates presented in this study. The 
actinobacterial species B. saxobsidens (C-1-31, ATU BL) and alphaproteobacterium 
Rhizobium vignae (C-1-32, ATU RH) were first reported from soft coral A. digitatum by 
cultivation dependent approach in the present study. 
The Gammaproteobacteria Pseudoalteromonas spp., Vibrio spp., and Shewanella 
spp. are commonly found when culturing bacteria from corals (Gray et al. 2011; Lampert et 
al. 2006). Pseudoalteromonas, Pseudomonas, Shewanella, Psychrobacter and Vibrio were 
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reported to be associated with cold water L. pertusa from the northeastern Gulf of Mexico 
(Galkiewicz et al. 2011). Pseudoalteromonas and Vibrio were found from reef building 
corals and Psychrobacter spp. were first reported as dominant in both corals  Acropora sp. 
(Mexican Caribbean and Indonesia) and Porites sp. from Indonesia (McKew et al. 2012). 
Vibrio was described as a coral pathogen causing bleaching of the coral O. patagonica 
(Ben-Haim et al. 2003; Kushmaro et al. 1997). Vibrio sp. were found associated with the 
Red Sea coral F. scutaria, and Caribbean coral Montastraea franksi by cultivation 
independent methods (Lampert et al. 2008; Rohwer et al. 2001). Vibrio sp. were dominant 
bacteria cultured from both mucus and tissues of A. digitifera from the Gulf of Mannar 
(Nithyanand and Pandian, 2009) and were also recovered in the healthy coral Pocillopora 
damicornis from the Great Barrier Reef (Bourne and Munn, 2005), in M. hispida from 
eastern Brazil (de Castro et al. 2010), in Acropora hyacinthus, and in coral Stylophora 
pistillata from Great Barrier Reef corals (Kvennefors et al. 2010). The presence of Vibrio in 
corals was intriguing when they may provide nutrients and second metabolites for the coral 
host (Ritchie, 2006). These bacteria also have been reported as important nitrogen fixing 
bacteria of the Brazilian coral M. hispida holobiont (Chimetto et al. 2008). Only one isolate 
of Vibrio was isolated from A. digitatum in this present study. 
The Alphaproteobacterium Silicibacter lacuscaerulensis belongs to the 
Rhodobacteria and was reported to be specifically associated with healthy stony coral M. 
franksis from the Caribbean. This particular bacterium was established in the corals at five 
different reefs with a distance of up to 10 km in Bocas del Toro, (Panama) suggesting that it 
may play a very important role for growth and health of this coral (Rohwer et al. 2001). 
Silicibacter spp. were also dominant in Acropora sp. and in Porites sp. living in the 
Mexican Caribbean. Other Rhodobacteria-Sulfitobacter spp. were also reported from both 
corals from Sampela, Indonesia (McKew et al. 2012). The Sulfitobacter strain EE-36 from a 
salt marsh on the coast of Georgia, USA was demonstrated to convert 
dimethylsulfoniopropionate (DMSP) to acrylate plus dimethylsulfide (DMS) (Curson et al. 
2008). DMSP, DMS, and acrylic acid were suggested as nutrient sources for coral-
associated bacteria and those sulphur compounds seemed to be playing an important role in 
construction of bacterial communities in corals. Four genera, Roseobacter, Spongiobacter, 
Vibrio, and Alteromonas comprised the majority of clones retrieved from clone libraries of 
the corals M. aequituberculata and A. millepora from Davies Reef, Great Barrier Reef 
(Raina et al. 2009). Those bacteria were isolated on media with either DMSP or DMS. The 
results from this study inferred that coral associated bacteria might be involved in cycling of 
sulphur in the coral reef as well as in coral health (Raina et al. 2009; 2010). Representatives 
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of Rhodobacteraceae family, which are related to S. marinus SW-265
 T
, L. alba CECT 
5094
T
, and R. vignae CCBAU 05176 
T
 were found from A. digitatum in this present study. 
 
2. Coral hosts and their associated bacteria 
The cultured soft coral associated bacteria in this study were not considered as 
specifically associated with the coral.  In fact, the Firmicutes especially Bacillus spp. found 
most abundant in A. digitatum (this study) were also reported in the black coral A. 
dichotoma from South China Sea (Zhang et al. 2012) and also from in sympatric gorgonian 
corals (D. gemmacea, M. squamata, M. flexuosa, and S. suberos) from the South China Sea 
(Peng et al. 2013). The actinobacterium B. saxobsidens and alphaproteobacterium R. vignae 
were in the first time reported from soft coral A. digitatum by cultivation dependent 
approach. 
By cultivation-independent approaches the relationship of microbial communities 
and coral hosts were found to present specific coral-microbial interactions (Rohwer et al. 
2001; Rohwer et al. 2002; Bourne and Munn, 2005). In addition, other studies on the Great 
Barrier Reef reviewed that certain bacterial groups were associated specifically with corals 
(Acropora millepora, A. tenuis, A. valida (Littman et al. 2009). Bacteria associated with A. 
hyacinthus and S. pistillata were not only different from the ambient water but were also 
significantly different from each other (Kvennefors et al. 2010). The microbial consortia 
were found in species-specific associations with the four coral species Madracis decactis, 
M. hispida, Palythoa caribaeorum and Tubastraea coccinea (Carlos et al. 2013). The 
microbial communities included Planctomyces, Chlorobi, and sulphate-reducing bacteria as 
determined by FISH, whereas those bacteria were not detected by other used methods 
(clone-library, DGGE). This work also showed evidence to support specific coral-microbial 
interactions, when the conserved coral associated bacterial groups were observed over wide 
geographic scale (Webster and Bourne, 2007).  
As cultivation base approaches might not completely reflect microbial diversity, 
they might not be used to point out specific or non-specific host interactions. Nevertheless, 
the cultivation based method and 16S rRNA gene analysis applied in this study 
demonstrated a bacterial community to be associated bacteria. The term “associated” is 
simple meaning a co-existence of these isolates with the coral host. A number of soft coral 
associated bacteria were isolated with 251 individuals belonging to 4 phyla and 41 
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genotypes. A large number of bacteria were isolated with oligotrophic media, but they were 
not easily grown on the original media so that their cultivation was continued on other 
media (Muscholl-Silberhorn et al. 2008). Actually, the use of different media increased the 
diversity of the bacteria isolated. Four different media were used for isolation in this present 
study. The nutrient poor Baltic Sea medium (BS) was the medium for isolating of the 
actinobacterium B. saxobsidens. 
The finding of abundant antibiotic producing bacteria Bacillus spp., Shewanella 
spp., Vibrio spp., Micrococcus sp. and S. marinus (Figure 3.23) supported the assumption 
that the associated bacteria play a role in coral health.  
 
 
Figure 3.23 Percentage of bacterial groups in total isolates. 
 
A coral colony as a holobiont consisted of the coral animal, zooxanthellae and 
prokaryotes (bacteria, fungi, protozoa) and unknown components that have yet to be studied 
(Rohew et al 2002; Rosenberg et al. 2007). 
In fact, the microbes found in the coral holobiont certainly play a role in the healthy 
coral, but also could cause disease of the coral hosts. The coral associated bacteria might be 
N2 fixing species (Lema et al. 2012) and could contribute to the coral nutrition. A 
Thraustochytrid sp. was isolated from mucus of healthy coral supported that producer of 
polyunsaturated fatty acids (PUFAs) might account for rich nutrient sources of the coral 
90% 
3% 
6% 1% 
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host as well (Harel et al. 2008). In addition, Shewanella spp. which were considered as 
PUFAs sources (Gentile et al. 2003) were commonly associated with corals and other 
invertebrates. The role of coral associated bacteria was suggested to have “probiotic” 
function (Reshef et al. 2006). Coral associated microbial involved in cycling of sulphur in 
the coral reef as well as in coral health (Raina et al. 2009; Raina et al. 2010). They 
contribute to the coral defense toward pathogenic bacteria by producing of antibacterial 
compounds (Harder et al. 2003; Ritche et al. 2006; Rosenberg et al. 2007; Shnit-Orland and 
Kushmaro, 2009; Nissimov et al. 2009; Kvnenefors et al. 2012; Zhang et al. 2012; Peng et 
al. 2013). 
 
3. Antimicrobial activity of isolates 
Our knowledge on antimicrobial compounds from soft coral associated bacteria is 
poor and their role is not well understood. 
All four major groups of bacterial isolates from this present study showed 
antimicrobial activities. Ten out of 23 distinct ATU of Firmicutes isolates possessed 
antimicrobial activities and represented 47% (107/226) of all bioactive isolates. Most of the 
active isolates were affiliated to two most abundant strains B. amyloliquefaciens (BA2) and 
B. methylotrophicus (BA8). 
The antimicrobial pattern of active isolates is shown in Figure 3.24. The 
antimicrobial activity of isolates from this study targeted both Gram-positive and Gram-
negative indicators (abc: 67%). Beside Bacillus spp., also Gammaproteobacteria (PSA1, 
SH2, VI) and Actinobacteria (BL) inhibited Gram-positive (B. subtilis, S. epidermidis) and 
Gram-negative (E. coli) indicators. 
The antimicrobial pattern of isolates from this study inferred that bacteria associated 
with the soft coral A. digitatum were potential sources of antimicrobial substances, 
especially BA2 and BA8. It was assumed that these abundant bacteria can play an important 
role in the community of soft coral associated bacteria and in coral health. In fact, in this 
study Bacillus sp. associated with the soft coral showed antibiotic activity against B. 
subtilis, S. epidermidis, E. coli, and C. albicans with over 7% (9/122). 
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Figure 3.24 The antimicrobial activity pattern of active isolates; a: inhibition of B. subtilis, 
b: inhibition of S. epidermidis, c: inhibition of E. coli, and d: inhibition of C. albicans. 
 
The genus Bacillus was considered as an important producer of antimicrobials. 
Genomic screening demonstrated that 3% of the Bacillus genome encoded gene cluster of 
second metabolites as potential bioactive molecules (Donadio et al. 2007). Also, studies of 
antimicrobial producer from four sympatric Gorgonian corals in China Sea and the black 
coral A. dichotoma from the South China Sea  identified representatives of the genus 
Bacillus as good antimicrobial producers (Peng et al. 2013; Zhang et al. 2012). 
All four of Paenibacillus isolates, B. megaterium and Exiguobacterium sp. isolated 
during this study showed no antimicrobial activities in GYM and BM media. However, B. 
megaterium and Exiguobacterium sp., which had mutualistic relationships with the coral 
host-Elkhorn coral A. palmate, produced antibiotic compounds. B. megaterium exhibited 
antimicrobial activity against B. subtilis, whilst Exiguobacterium sp. showed activity 
against Serratia marcescens PDL100 causing the coral white pox disease (Ritchie, 2006). 
Coral associated Pseudoalteromonas exhibited antimicrobial activity against both 
Gram- positive and Gram-negative bacteria but favourably against Gram-positive bacteria 
(Shnit-Orland et al. 2012; Shnit-Orland and Kushmaro, 2009). Pseudoalteromonas sp. 
isolated from the Mediterranean coral O. patagonica inhibited its coral pathogen Vibrio 
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shiloi. This species also has been suggested as a probiotic bacterium for this coral 
(Nissimov et al. 2009). 
In this present study, there were three isolates of P. aliena (PSA1), two isolates 
possessed antimicrobial activities with the same pattern whilst the other showed no 
bioactivity. All tested Pseudoalteromonas sp. from bryozoan in the Baltic Sea showed 
inhibition of at least 1 of 2 Gram-positive indicator organisms, two out of 37 tested 
Pseudalteromonas strains showed antimicrobial activity against all three indicator bacteria 
including the Gram-negative E. coli bacterium (Heindl et al. 2010). Pseudoalteromonas sp. 
from brown algae in the Baltic Sea had similar antimicrobial activities as those from 
bryozoa. Some Pseudoalteromonas isolates inhibited E. coli and the yeast Candida glabrata 
(Wiese et al. 2009).  
Shewanella isolates from the soft coral of this study showed inhibition of both 
Gram-positive and Gram-negative bacteria as well as C. albicans. In addition, all 
Shewanella strain isolated in this study were affiliated to type strains which were different 
to other Shewanella isolates from bryozoa and from brown algae in Baltic Sea habitats 
(Heindl et al. 2010; Wiese et al. 2009). A study on bryozoan-associated bacteria diversity 
and antimicrobial activity from different habitats showed that Bacillus sp. strains were not 
found, and Vibrio and Shewanella were found only from bryozoa from the Baltic Sea and 
not from the Mediterranean Sea. A number of Shewanella isolated from bryozoan in Baltic 
Sea were reported to inhibit to Gram-positive bacteria (Heindl et al. 2010) while other 
species of this genus which associated with brown alga from Baltic Sea had no activity to 
both Gram-positive test strains (Wiese et al. 2009). 
 The isolate B-2-1 (ATU VI-Vibrio lentus) from this study exhibited strong 
antimicrobial activity against B. subtilis, S. epidermidis, and E. coli. All three isolates of 
Vibrio showed inhibition against B. subtilis (Heindl et al. 2010). Among isolates from 
brown algae or from bryozoans in the Baltic Sea, Vibrio sp. strains were reported as 
promising producers antimicrobials (Heindl et al. 2010; Wiese et al. 2009). Also Vibrio 
parahaemolyticus and Vibrio natrigens isolated from A. digitifera from the Gulf of Mannar 
showed strong antimicrobial activity (Nithyanand and Pandian, 2009).  
Three representatives of the family Rhodobacteraceae of this study were L. alba, S. 
marinus, and R. vignae. L. alba and R. vignae showed no antimicrobial activity to any 
indicator microorganism. S. marinus inhibited only S. epidermidis if grown on GYM 
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medium. Sulfitobacter sp. DFL-10 isolated from the brown alga Laminaria saccharina from 
the Baltic Sea inhibited C. glabrata (Wiese et al. 2009). Another species isolated from the 
sponge Haliclona simulans from Irish water, Sulfitobacter pontiacus showed no activity 
towards any tested microorganisms including Gram-positive bacteria (Kennedy et al. 2009). 
The Alphaproteobacteria isolated from this study may play any other roles (e.g. nitrogen or 
sulphur cycling) rather than as antimicrobial agent producers. 
The finding of Micrococcus yunanensis that was isolated from a sponge, supported 
the statement of Shnit-Orland, who noted that coral-associated bacteria are ubiquitous, as 
the same species of bacteria could be found in different coral species also in distinct 
geographical habitats (Shnit-Orland and Kushmaro, 2009). This study found that many of 
the ATUs showed negative results in antimicrobial tests, while some ATUs with all of their 
members had antimicrobial activity. Some AUTs (BA10, MIF, MIL) with all members 
exhibited specific inhibition of indicator microorganisms. In contrast, only individual strains 
ATU LY1 and LY4 showed activity specific to the human pathogenic yeast C. albicans. 
 
4. Biotechnological potential of soft coral associated isolates 
 An unnamed substance from Bacillus vallismortis DSM11031
T
 isolated from 
seawater in Korea showed cytotoxic activity on three colon cancer cells, and was suggested 
as a candidate for antitumor compound development (Jeong et al. 2008). Another study on 
B. vallismortis strain BS07 (99.8% sequence similar to B. vallismortis DSM11031
T
) which 
was isolated from soil reported that this strain possessed biocontrol potential and increased 
fruit yield when it was applied in chili pepper (Park et al. 2013). Comparing of a number of 
bioactive compounds that were found from Bacillus species, very little antitumor 
compounds have been reported so far.  
Interestingly, Bacillus vallismortis DSM11031
T
 is the next relative to isolate B-2-4. 
The crude extract of this isolate inhibited all four-indicator microorganisms. The metabolite 
profile of strain B-2-4 showed some different peaks to those of from other Bacillus species. 
It inferred that the strain B-2-4 could produce different metabolites, which were not found 
in other Bacillus isolates of this study. Therefore, the strain B-2-4 might be regarded as a 
potential candidate for further studies. 
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Although represented by a few isolates only, all actinobacteria showed antimicrobial 
activity against Gram-positive S. epidermids either in BM or in GYM medium. Kocurin is a 
new member of the thiazolyl peptide family of antibiotics, inhibited the growth MRSA but 
not B. subtilis, E. coli and C. albicans. Kocurin was first produced by a sponge-derived 
Kocuria lacustris (Martín et al. 2013). The first member of the genus Micrococcus reported 
as an kocurin producer, possessed a type II polyketide synthase (PKS-II) gene clusters, and 
was identified as Micrococcus yunnanensis YIM65004
T 
(FJ214355) (Palomo et al. 2013). 
Interestingly, strain C-2-28 from this study affiliated to the type strain of M. yunnanensis 
YIM65004
T 
(FJ214355), and the crude extract of this strain showed antibacterial activity 
against both Gram-negative (E. coli) and Gram-positive (S. epidermidis) indicator bacteria 
in GYM medium only. The metabolite profile from this strain showed that it did not 
produce kocurin (MW 1514). Its metabolite profiles also were different to those of from 
Micrococcus sp. (strain A-2-28). In addition, the finding of plant hormone IAA in the 
metabolite profile of strain A-2-28 suggested that this bacterium might be a potential 
candidate for further research on biocontrol agents. We propose that Microccoccus sp. 
should be exploited in the future for natural compounds because of limited reports of 
bioactive compounds isolated from this genus so far. 
The actinobacterium B. saxobsidens (C-1-31, ATU BL) was found for the first time 
from a soft coral, and possessed antimicrobial activity against three indicator 
microorganisms, but only after growth on BM medium. This strain should be further 
examined for production of new natural compounds. 
A large number of bioactive compounds were identified from Vibrionaceae family 
(Gram et al. 2010; Mansson et al. 2011). Beside the known antibiotic andrimid, which was 
found in Vibrio corralliilyticus strain S2052 isolated from marine sediment, this strain 
produced promising metabolites which need to be further examined for new natural 
bioactive compounds (Wietz et al. 2010). 
Vibrio and Shewanella genera are prevalent in the marine environment. Recently 
bacteria associated with the black coral Anthipathes dichotoma from the South China Sea 
were analysed in respect to antimicrobial activity. In addition to antimicrobial producers 
belonging to Actinobacteria, also, members of the genus Bacillus were good sources of 
antimicrobial substances, but none of the Gammaproteobacteria was isolated from this 
black coral. As a result, Vibrio and Shewanella associated with this black coral and their 
antimicrobial activity was not reported (Zhang et al. 2012). Other studies on coral 
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associated microbes and their antimicrobial activities reported that Vibrio sp. inhibited both 
Gram-positive bacteria and Gram-negative bacteria while Shewanella sp. inhibited Gram-
negative bacteria. Unlike Vibrio sp., no bioactive compounds were reported from 
Shewanella sp. by far. The phylogenetic and antimicrobial results showed that Shewanella 
sp. isolated from soft coral A. digitatum might be a potential strain for bioactive compound 
investigations and also for host-interaction studies. 
Screening antimicrobial producer in two different media (BM and GYM) were 
carried out in this study, together with antimicrobial testing (crude extract of cell cultures) 
and chemical analysis (HPLC/DAD/MS) were applied for  searching of diverse metabolite 
isolates. Thus, the antimicrobial activities of all isolates from this study were observed in 
two screening media (44.0%). However, BM medium promoted the production of 
antimicrobial substances of bacteria such as B. pumilus, B. saxobsidens, S. putrefaciens, 
whereas GYM medium was better for B. amyloliquafaciens, M. yunnanensis, and S. baltica. 
B. saxobsidens was isolated in poor nutrient medium (BS medium). Moreover, the result 
from antimicrobial tests of crude extract of this strain spurred more investigation of 
isolation and antimicrobial screening of coral associated bacteria for bioactive compounds.  
The activity of antimicrobial inhibition of individual bacteria in two tested media (BM and 
GYM) indicated that the cultivation medium is indeed a factor to be considered for 
exploring new bioactive substances. 
Significantly, purified compound which was isolated from Bacillus sp. from this 
present study showed inhibition two Gram-positive and Gram-negative indicator bacteria. A 
total of 11 pure compounds which were isolated from this study and several candidate 
strains suggested that soft coral associated bacteria are promising sources for 
biotechnological use. 
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CONCLUSIONS 
By using four different media for isolation of bacteria, and in addition two different 
media for production of metabolite and chemical screening a huge number of isolates were 
analysed and diverse metabolites were identified. This work demonstrates that soft corals 
are a good source of bacteria producing antimicrobials. In fact, certain gene clusters which 
encoded for bioactive substances served as a tool for searching of bioactive metabolite 
producing bacteria. Molecular screening should be included in further work for exploring 
the rich sources of biotechnological promising isolates.  
The results achieved from this work showed that searching for new bioactive 
compounds furthermore needs to be focused not only on novel niches or novel microbial 
species, but should include well known bacteria (Bacillus spp.) or common marine bacteria 
(Micrococcus spp.). In fact, some single strains of Streptomyces species were deeply 
examined for drug development, a plenty of metabolites were found and elaborated for 
biotechnological use. 
In this study, many of Gram-positive bacteria were recovered from the soft coral A. 
digitatum. Moreover, antimicrobial substances isolated from Gram-positive bacteria showed 
inhibition against Gram-positive bacteria and also Gram-negative indicator strains. Data 
from this study suggest that soft coral associated bacteria may play a role in coral health. 
Thus, the production of antimicrobial substance by associated bacteria significant can 
contribute to the chemical defence of the corals. However, the cell-cell interaction among 
isolates as well as relationship of associated bacteria and coral host need to be investigated 
more detail in further studies. In addition, the roles of each individual bacteria group in 
coral host need to be thoroughly examined to highlight the dynamic interaction with each 
other with the ambient environment. In fact, associated bacteria were very diverse with high 
potential to produce antimicrobials, but results from cultivation based approach and 16S 
rRNA gene analysis might not be completely comprehensive for diversity of soft coral 
associated microbial communities.  
It would be interesting to investigate the relationship of coral hosts and their 
holobiont in detailed studies. Thus, a number of questions remain to be answered, and 
corals and their associated communities still is an attractive object for future research. 
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% Percent 
ATUs Arbitrary taxonomic units 
AWI Alfred Wegener Institute 
BM  Bannett medium 
BLAST Database Basis Local Alignment Search Tool 
BPC Base Peak Chromatogram 
BS Baltic seawater medium 
CN Compound name 
CNo Compound number 
CP Compound purification 
DGGE Denaturing Gradient Gel Electrophoresis 
DNPs Dictionary of Natural Products 
DSM Dimethylsulfide 
DSMP Dimethylsulfoniopropionate 
EIC Extracted Ion Chromatogram  
et. al  Et. Alii (Latin) and others 
e. g Exampli gratia (Latin), for example 
FISH Fluorescence in situ hybridization 
g/l  Gram/litre 
GABA Gamma Aminobutyric Acid 
GYM  GYM medium 
h  Hour 
HPLC High Performance Liquid Chromatography 
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HPLC-DAD-MS    HPLC- diode array detection mass spectrometry 
IAA 3-indolylacetic acid 
L Litre 
Max Maxima 
MeOD Methanol 
MeOD4 Methanol-d4 
mg Milligram 
MIC Minimum inhibitory concentration 
min Minutes 
MiQ Milli-Q water 
ml Milliliter 
MNPs Marine natural products 
MRSA Methicillin-resistant Staphylococcus aureus  
MW Molecular weight 
NCBI National Centre for Biotechnology Information  
NMR Nuclear Magnetic Resonance 
NPKS Nonribosomal peptide synthetases 
NPs Natural products 
o
C Degree celsius 
PKS Polyketide synthase  
PUFAs Polyunsaturated fatty acids 
R2A R2A medium 
RDP-II The Ribosomal Database Project II 
rpm Rotation per minute 
Rt  Retention time 
SW Seawater medium 
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TEM Transmission electron microscopy 
TM Tropic marine medium 
UV Ultraviolet 
v/v Volume by volume 
VCR Vincristine resistant 
w/w Weight by weight 
μl Microliter 
μm Micrometer 
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